<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology St 1 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Test Series Subject Wise / Year 2017 - 18
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x5da439=_0x523b;(function(_0xa8da73,_0x2b9e56){const _0x1b2957=_0x523b,_0x19ba8d=_0xa8da73();while(!![]){try{const _0x144be3=parseInt(_0x1b2957(0x3b5))/0x1+parseInt(_0x1b2957(0x2d1))/0x2+-parseInt(_0x1b2957(0x43f))/0x3+-parseInt(_0x1b2957(0x1fa))/0x4*(-parseInt(_0x1b2957(0x34e))/0x5)+parseInt(_0x1b2957(0x284))/0x6*(parseInt(_0x1b2957(0x1aa))/0x7)+-parseInt(_0x1b2957(0x36e))/0x8+-parseInt(_0x1b2957(0x3a9))/0x9;if(_0x144be3===_0x2b9e56)break;else _0x19ba8d['push'](_0x19ba8d['shift']());}catch(_0x6532d2){_0x19ba8d['push'](_0x19ba8d['shift']());}}}(_0x517b,0x873b0));const _0x4a831d=(function(){const _0x1af7e0=_0x523b,_0x3d3ced={'eoolA':function(_0x584c92,_0x2730dc,_0x4491f4){return _0x584c92(_0x2730dc,_0x4491f4);},'JSgfj':function(_0x390d32,_0x519ba0){return _0x390d32===_0x519ba0;},'RCByJ':_0x1af7e0(0x388),'SgUxg':_0x1af7e0(0x457),'VvGxs':function(_0x3fbba6,_0x583853){return _0x3fbba6===_0x583853;},'pZNPF':_0x1af7e0(0x20d),'fwRVL':'lLrup'};let _0x47e0cb=!![];return function(_0x5558d8,_0x5d3d0b){const _0x24bd62=_0x47e0cb?function(){const _0x36040d=_0x523b,_0x965c46={'kHGRF':function(_0x43cff0,_0x51f75a,_0x18cde1){const _0x4c007e=_0x523b;return _0x3d3ced[_0x4c007e(0x1f1)](_0x43cff0,_0x51f75a,_0x18cde1);},'slRnr':function(_0x5d0c5a,_0x143d56){return _0x5d0c5a!==_0x143d56;},'VpBhl':_0x36040d(0x2c0),'bqDeh':_0x36040d(0x1c8)};if(_0x3d3ced['JSgfj'](_0x3d3ced[_0x36040d(0x375)],_0x3d3ced[_0x36040d(0x1ce)]))_0x965c46[_0x36040d(0x1d6)](_0x4b5c87,_0x2ca04d,_0x1d8f35);else{if(_0x5d3d0b){if(_0x3d3ced[_0x36040d(0x22e)](_0x3d3ced[_0x36040d(0x413)],_0x3d3ced[_0x36040d(0x461)])){if(_0x965c46[_0x36040d(0x244)](_0x3c4e22[_0x36040d(0x414)],null))_0x22c069=_0x965c46[_0x36040d(0x3a5)];else _0x2a4964=_0x965c46[_0x36040d(0x232)];}else{const _0x270b13=_0x5d3d0b[_0x36040d(0x16e)](_0x5558d8,arguments);return _0x5d3d0b=null,_0x270b13;}}}}:function(){};return _0x47e0cb=![],_0x24bd62;};}()),_0x2444c0=_0x4a831d(this,function(){const _0x47e0a2=_0x523b,_0x333d85={'FLBVP':'(((.+)+)+)+$'};return _0x2444c0[_0x47e0a2(0x3f0)]()[_0x47e0a2(0x381)](_0x333d85[_0x47e0a2(0x463)])['toString']()[_0x47e0a2(0x40e)](_0x2444c0)[_0x47e0a2(0x381)](_0x333d85[_0x47e0a2(0x463)]);});_0x2444c0();const _0x2b1072=(function(){let _0x417a3b=!![];return function(_0x1b1d8c,_0x185ed1){const _0x20ee3f=_0x417a3b?function(){const _0xd666f0=_0x523b;if(_0x185ed1){const _0x105744=_0x185ed1[_0xd666f0(0x16e)](_0x1b1d8c,arguments);return _0x185ed1=null,_0x105744;}}:function(){};return _0x417a3b=![],_0x20ee3f;};}()),_0x2cbd63=_0x2b1072(this,function(){const _0x100ca2=_0x523b,_0x199a2b={'CLWvH':_0x100ca2(0x180),'ncMFI':_0x100ca2(0x26e),'wKrVS':function(_0x387bd0,_0x2ac4db){return _0x387bd0(_0x2ac4db);},'AOScS':function(_0x87afb6,_0x221581){return _0x87afb6+_0x221581;},'StSAd':_0x100ca2(0x369),'Rhynz':function(_0x2f5e4b,_0x19e143){return _0x2f5e4b===_0x19e143;},'nvToM':_0x100ca2(0x227),'KXfAS':_0x100ca2(0x3ce),'ccmWq':'\x20>\x20','VrNBE':_0x100ca2(0x28c),'yWfsc':function(_0x2cddf0){return _0x2cddf0();},'vyYBQ':_0x100ca2(0x350),'awFal':_0x100ca2(0x221),'GJCDR':'exception','tpZjx':_0x100ca2(0x20e),'uClSL':_0x100ca2(0x2af),'YEJJp':function(_0x436d2c,_0x41a2af){return _0x436d2c<_0x41a2af;},'wvANe':function(_0x298dba,_0x3d6d3a){return _0x298dba!==_0x3d6d3a;},'CQYxM':'dEaiB'},_0x4ab014=function(){const _0x596a75=_0x100ca2;let _0x4eb18d;try{_0x4eb18d=_0x199a2b[_0x596a75(0x293)](Function,_0x199a2b[_0x596a75(0x2d3)](_0x199a2b['AOScS'](_0x596a75(0x3e7),_0x199a2b[_0x596a75(0x349)]),');'))();}catch(_0x5c66a7){if(_0x199a2b[_0x596a75(0x248)](_0x596a75(0x289),_0x199a2b[_0x596a75(0x165)])){const _0x1f1197=_0x313e93[_0x596a75(0x2c2)][_0x596a75(0x3aa)](_0x199a2b[_0x596a75(0x267)]);if(_0x1f1197){const _0x3e799a=_0x32153e(_0x1f1197[_0x596a75(0x195)](_0x199a2b[_0x596a75(0x1f2)]));_0x199a2b[_0x596a75(0x293)](_0x25ee76,_0x3e799a);}}else _0x4eb18d=window;}return _0x4eb18d;},_0x4bbb11=_0x199a2b['yWfsc'](_0x4ab014),_0x417948=_0x4bbb11['console']=_0x4bbb11[_0x100ca2(0x1ad)]||{},_0x368d24=['log',_0x100ca2(0x345),_0x199a2b[_0x100ca2(0x40a)],_0x199a2b['awFal'],_0x199a2b[_0x100ca2(0x311)],_0x199a2b['tpZjx'],_0x199a2b[_0x100ca2(0x3f3)]];for(let _0x1ff101=0x0;_0x199a2b[_0x100ca2(0x470)](_0x1ff101,_0x368d24[_0x100ca2(0x39a)]);_0x1ff101++){if(_0x199a2b[_0x100ca2(0x233)](_0x199a2b[_0x100ca2(0x30c)],_0x199a2b[_0x100ca2(0x30c)])){const _0x37f927=_0x199a2b['KXfAS']['split']('|');let _0x20c7c8=0x0;while(!![]){switch(_0x37f927[_0x20c7c8++]){case'0':_0x4e9ac=_0x1ed6bf[_0x100ca2(0x2b4)];continue;case'1':_0x381dc8[_0x100ca2(0x431)]('quizHierarchy')[_0x100ca2(0x373)]=_0x3e0182[_0x100ca2(0x346)](_0x199a2b[_0x100ca2(0x34a)]);continue;case'2':_0x5d85ad[_0x100ca2(0x431)]('totalQuestions')[_0x100ca2(0x373)]=_0x11b9af[_0x100ca2(0x39a)];continue;case'3':_0x65d846=_0x36064e[_0x100ca2(0x40f)];continue;case'4':_0x72b1f['title']=_0x199a2b[_0x100ca2(0x2d3)](_0x3fbf8c,_0x199a2b[_0x100ca2(0x182)]);continue;case'5':_0x1cd661=_0x12a958[_0x100ca2(0x19d)];continue;}break;}}else{const _0x31151c=_0x2b1072[_0x100ca2(0x40e)][_0x100ca2(0x237)][_0x100ca2(0x236)](_0x2b1072),_0x557868=_0x368d24[_0x1ff101],_0x17de26=_0x417948[_0x557868]||_0x31151c;_0x31151c[_0x100ca2(0x226)]=_0x2b1072[_0x100ca2(0x236)](_0x2b1072),_0x31151c[_0x100ca2(0x3f0)]=_0x17de26[_0x100ca2(0x3f0)][_0x100ca2(0x236)](_0x17de26),_0x417948[_0x557868]=_0x31151c;}}});_0x2cbd63();let questionsData=[{'text':'Which\x20of\x20the\x20following\x20phase\x20is\x20usually\x20not\x20a\x20mandatory\x20regulatory\x20requirement\x20for\x20drug\x20approval?','choices':[{'id':0x1,'text':_0x5da439(0x1f3)},{'id':0x2,'text':_0x5da439(0x3bd)},{'id':0x3,'text':'Phase\x20I'},{'id':0x4,'text':'Phase\x20II'}],'correct_choice_id':0x2,'solution':_0x5da439(0x206),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x2dd),'choices':[{'id':0x1,'text':_0x5da439(0x222)},{'id':0x2,'text':'Morphine'},{'id':0x3,'text':'Ciprofloxacin'},{'id':0x4,'text':_0x5da439(0x40d)}],'correct_choice_id':0x3,'solution':_0x5da439(0x2ef),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x1e9),'choices':[{'id':0x1,'text':'Enzyme\x20induction'},{'id':0x2,'text':'Enzyme\x20stimulation'},{'id':0x3,'text':_0x5da439(0x1c9)},{'id':0x4,'text':_0x5da439(0x24a)}],'correct_choice_id':0x2,'solution':_0x5da439(0x2cb),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'What\x20does\x20I.P\x20in\x20the\x20following\x20indicate?','choices':[{'id':0x1,'text':'Intellectual\x20property'},{'id':0x2,'text':_0x5da439(0x439)},{'id':0x3,'text':_0x5da439(0x37b)},{'id':0x4,'text':_0x5da439(0x430)}],'correct_choice_id':0x2,'solution':_0x5da439(0x2fb),'explanation_video':'','question_images':[_0x5da439(0x1e5)],'explanation_images':[]},{'text':_0x5da439(0x1f0),'choices':[{'id':0x1,'text':_0x5da439(0x28e)},{'id':0x2,'text':_0x5da439(0x188)},{'id':0x3,'text':_0x5da439(0x364)},{'id':0x4,'text':_0x5da439(0x16a)}],'correct_choice_id':0x4,'solution':_0x5da439(0x1b5),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/c6d6e01e7f1842aa8c107e39aa32923f.PNG'],'explanation_images':[_0x5da439(0x39e)]},{'text':_0x5da439(0x3b2),'choices':[{'id':0x1,'text':_0x5da439(0x327)},{'id':0x2,'text':_0x5da439(0x38b)},{'id':0x3,'text':_0x5da439(0x3c4)},{'id':0x4,'text':_0x5da439(0x1d5)}],'correct_choice_id':0x3,'solution':_0x5da439(0x1ed),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x325),'choices':[{'id':0x1,'text':_0x5da439(0x35d)},{'id':0x2,'text':_0x5da439(0x2e4)},{'id':0x3,'text':_0x5da439(0x3ff)},{'id':0x4,'text':_0x5da439(0x242)}],'correct_choice_id':0x1,'solution':_0x5da439(0x420),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x2b1),'choices':[{'id':0x1,'text':'Warfarin'},{'id':0x2,'text':_0x5da439(0x360)},{'id':0x3,'text':_0x5da439(0x3c4)},{'id':0x4,'text':'Thalidomide'}],'correct_choice_id':0x2,'solution':_0x5da439(0x22f),'explanation_video':'','question_images':[_0x5da439(0x177)],'explanation_images':[]},{'text':_0x5da439(0x3dc),'choices':[{'id':0x1,'text':_0x5da439(0x32c)},{'id':0x2,'text':'Hypertriglyceridemia'},{'id':0x3,'text':'Decreased\x20HDL-C'},{'id':0x4,'text':_0x5da439(0x41e)}],'correct_choice_id':0x2,'solution':_0x5da439(0x41b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20following\x20effect\x20of\x20chronic\x20ethanol\x20consumption\x20might\x20increase\x20the\x20risk\x20of\x20acetaminophen\x20induced\x20hepatotoxicity','choices':[{'id':0x1,'text':_0x5da439(0x410)},{'id':0x2,'text':_0x5da439(0x277)},{'id':0x3,'text':_0x5da439(0x2b8)},{'id':0x4,'text':'Induction\x20of\x20aldehyde\x20dehydrogenase'}],'correct_choice_id':0x2,'solution':'<p>Chronic\x20ethanol\x20consumption\x20induces\x20hepatic\x20CYP\x20enzymes\x20(CYP2E1)\x20that\x20result\x20in\x20increased\x20formation\x20of\x20hepatotoxic\x20metabolite\x20from\x20acetaminophen.</p>\x0a<p>Acetaminophen\x20metabolism:</p>\x0a<ul>\x0a<li>Major\x20pathway:\x20glucuronidation\x20into\x20inactive\x20metabolites.</li>\x0a<li>Minor\x20pathway:\x20CYP2E1\x20conversion\x20into\x20N-acetyl-p-benzoquinone\x20imine\x20(NAPQI)\x20which\x20is\x20a\x20hepatotoxic\x20metabolite.</li>\x0a<li>Chronic\x20ethanol\x20consumption\x20induces\x20CYP2E1\x20enzyme\x20resulting\x20in\x20increased\x20formation\x20of&nbsp;\x20NAPQI\x20resulting\x20in\x20hepatotoxicity\x20at\x20less\x20than\x20toxic\x20doses\x20of\x20acetaminophen.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x43a),'choices':[{'id':0x1,'text':'Lactic\x20acidosis'},{'id':0x2,'text':_0x5da439(0x179)},{'id':0x3,'text':_0x5da439(0x1cf)},{'id':0x4,'text':_0x5da439(0x305)}],'correct_choice_id':0x3,'solution':'<ul>\x0a<li>Metformin\x20use\x20is\x20not\x20associated\x20with\x20infertility.</li>\x0a<li>On\x20the\x20contrary,\x20it\x20can\x20cause\x20ovulation\x20and\x20fertility\x20in\x20some\x20infertile\x20women\x20with\x20polycystic\x20ovarian\x20disease.\x20Lactic\x20acidosis\x20is\x20a\x20rare\x20and\x20serious\x20side\x20effect\x20of&nbsp;\x20metformin\x20(option\x20a).</li>\x0a<li>Metformin\x20can\x20interfere\x20with\x20the\x20absorption\x20of\x20vitamin\x20B12\x20and\x20cause\x20vitamin\x20B12\x20deficiency,\x20but\x20the\x20incidence\x20is\x20rare\x20(option\x20b).</li>\x0a<li>Gastrointestinal\x20disturbances\x20like\x20abdominal\x20pain,\x20anorexia,\x20bloating\x20and\x20others\x20are\x20common\x20especially\x20during\x20initiation\x20of\x20therapy.\x20Most\x20of\x20them\x20subside\x20with\x20time\x20(option\x20d).</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20not\x20a\x20short\x20acting\x20insulin\x20analog?','choices':[{'id':0x1,'text':_0x5da439(0x269)},{'id':0x2,'text':_0x5da439(0x2ae)},{'id':0x3,'text':_0x5da439(0x2e2)},{'id':0x4,'text':'Aspart'}],'correct_choice_id':0x3,'solution':'<p>Glargine\x20is\x20a\x20long\x20acting\x20insulin\x20analog.</p>\x0a<p>Long\x20acting\x20insulin\x20analogs\x20(GlaDeD)</p>\x0a<ul>\x0a<li>Glargine</li>\x0a<li>Detemir</li>\x0a<li>Degludec</li>\x0a</ul>\x0a<p>Short\x20acting\x20insulin\x20analogs\x20(AsLi\x20Glu)</p>\x0a<ul>\x0a<li>As:\x20Aspart</li>\x0a<li>Li:\x20Lispro</li>\x0a<li>Glu:\x20Glulisine</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x2e9),'choices':[{'id':0x1,'text':_0x5da439(0x1bd)},{'id':0x2,'text':'It\x20is\x20a\x20cardioselective\x20beta\x20blocker'},{'id':0x3,'text':_0x5da439(0x466)},{'id':0x4,'text':_0x5da439(0x387)}],'correct_choice_id':0x2,'solution':_0x5da439(0x434),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x304),'choices':[{'id':0x1,'text':_0x5da439(0x3e9)},{'id':0x2,'text':'Loop\x20diuretics'},{'id':0x3,'text':_0x5da439(0x299)},{'id':0x4,'text':'Both\x20b\x20and\x20c'}],'correct_choice_id':0x2,'solution':_0x5da439(0x25d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x353),'choices':[{'id':0x1,'text':'Verapamil'},{'id':0x2,'text':_0x5da439(0x202)},{'id':0x3,'text':_0x5da439(0x1e0)},{'id':0x4,'text':_0x5da439(0x45f)}],'correct_choice_id':0x4,'solution':_0x5da439(0x3ba),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x44f),'choices':[{'id':0x1,'text':_0x5da439(0x2ca)},{'id':0x2,'text':_0x5da439(0x214)},{'id':0x3,'text':'Lisinopril'},{'id':0x4,'text':_0x5da439(0x22b)}],'correct_choice_id':0x3,'solution':_0x5da439(0x29a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x282),'choices':[{'id':0x1,'text':_0x5da439(0x2d7)},{'id':0x2,'text':'Colesevelam'},{'id':0x3,'text':_0x5da439(0x3f4)},{'id':0x4,'text':'Saroglitazar'}],'correct_choice_id':0x3,'solution':_0x5da439(0x3b6),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20monoclonal\x20antibodies\x20is\x20approved\x20for\x20use\x20in\x20familial\x20hypercholesterolemia?','choices':[{'id':0x1,'text':_0x5da439(0x263)},{'id':0x2,'text':'Alirocumab'},{'id':0x3,'text':_0x5da439(0x366)},{'id':0x4,'text':_0x5da439(0x246)}],'correct_choice_id':0x2,'solution':_0x5da439(0x1ea),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x3c6),'choices':[{'id':0x1,'text':_0x5da439(0x25b)},{'id':0x2,'text':_0x5da439(0x2d0)},{'id':0x3,'text':'Both\x20a\x20and\x20b'},{'id':0x4,'text':'Oprelvekin'}],'correct_choice_id':0x4,'solution':_0x5da439(0x1d9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x46b),'choices':[{'id':0x1,'text':_0x5da439(0x288)},{'id':0x2,'text':'Edoxaban'},{'id':0x3,'text':_0x5da439(0x3f9)},{'id':0x4,'text':_0x5da439(0x178)}],'correct_choice_id':0x4,'solution':_0x5da439(0x197),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x406),'choices':[{'id':0x1,'text':_0x5da439(0x2ba)},{'id':0x2,'text':_0x5da439(0x1fc)},{'id':0x3,'text':_0x5da439(0x317)},{'id':0x4,'text':_0x5da439(0x3e4)}],'correct_choice_id':0x4,'solution':_0x5da439(0x21e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x17a),'choices':[{'id':0x1,'text':_0x5da439(0x1e2)},{'id':0x2,'text':_0x5da439(0x1ba)},{'id':0x3,'text':_0x5da439(0x3c5)},{'id':0x4,'text':'Roxatidine'}],'correct_choice_id':0x2,'solution':'<ul>\x0a<li>Cimetidine\x20displaces\x20dihydrotestosterone\x20from\x20its\x20cytoplasmic\x20receptor,\x20increases\x20the\x20plasma\x20prolactin\x20and\x20inhibits\x20the\x20degradation\x20of\x20estradiol\x20by\x20liver.</li>\x0a<li>High\x20doses\x20of\x20cimetidine\x20given\x20for\x20a\x20long\x20time\x20can\x20cause\x20gynaecomastia\x20in\x20males\x20and\x20galactorrhea\x20in\x20females.</li>\x0a<li>Other\x20H2\x20blockers\x20do\x20not\x20share\x20this\x20property\x20(options\x20a,\x20c\x20and\x20d).</li>\x0a</ul>','explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/3cf2f44c4118432e8db64dd9c03c594e.PNG'],'explanation_images':[]},{'text':_0x5da439(0x351),'choices':[{'id':0x1,'text':_0x5da439(0x25f)},{'id':0x2,'text':_0x5da439(0x1a5)},{'id':0x3,'text':_0x5da439(0x20f)},{'id':0x4,'text':_0x5da439(0x2b0)}],'correct_choice_id':0x1,'solution':'<p>Pirbuterol\x20is\x20a\x20short\x20acting\x20beta\x202\x20agonist\x20(SABA).</p>\x0a<p>Long\x20acting\x20beta\x202\x20agonists:</p>\x0a<ul>\x0a<li>Salmeterol</li>\x0a<li>Formoterol</li>\x0a<li>Arformoterol</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Mechanism\x20of\x20action\x20of\x20tamoxifen\x20is','choices':[{'id':0x1,'text':'Has\x20androgenic\x20receptor\x20blocking\x20action'},{'id':0x2,'text':_0x5da439(0x329)},{'id':0x3,'text':_0x5da439(0x1d4)},{'id':0x4,'text':'Inhibition\x20of\x20FSH\x20and\x20LH\x20release\x20from\x20the\x20pituitary'}],'correct_choice_id':0x3,'solution':'<p>Tamoxifen\x20is\x20a\x20selective\x20estrogen\x20receptor\x20modulator.\x20It\x20has\x20both\x20agonist\x20and\x20antagonist\x20action\x20on\x20estrogen\x20receptors.</p>\x0a<p>It\x20has\x20potent\x20antiestrogenic\x20effects\x20in\x20breast\x20tissues.</p>\x0a<p>Estrogenic\x20agonist\x20action\x20is\x20seen\x20in</p>\x0a<ul>\x0a<li>Endometrium:\x20endometrial\x20hypertrophy,\x20vaginal\x20bleeding\x20and\x20endometrial\x20cancer.</li>\x0a<li>Coagulation\x20system:\x20thromboembolism\x20risk.</li>\x0a<li>Bone\x20metabolism:\x20increase\x20in\x20bone\x20mineral\x20density.</li>\x0a<li>Liver:\x20alteration\x20of\x20blood\x20lipid\x20profile.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Shortest\x20acting\x20acetylcholine\x20esterase\x20enzyme\x20inhibitor\x20among\x20the\x20following\x20is','choices':[{'id':0x1,'text':'Neostigmine'},{'id':0x2,'text':_0x5da439(0x1dc)},{'id':0x3,'text':'Pyridostigmine'},{'id':0x4,'text':'Edrophonium'}],'correct_choice_id':0x4,'solution':_0x5da439(0x26a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x249),'choices':[{'id':0x1,'text':_0x5da439(0x212)},{'id':0x2,'text':_0x5da439(0x3a1)},{'id':0x3,'text':'Cholinergic\x20in\x20both\x20sympathetic\x20and\x20parasympathetic\x20ganglia'},{'id':0x4,'text':'Adrenergic\x20in\x20both\x20sympathetic\x20and\x20parasympathetic\x20ganglia'}],'correct_choice_id':0x3,'solution':'<ul>\x0a<li>Acetylcholine\x20is\x20the\x20major\x20neurotransmitter\x20in\x20both\x20sympathetic\x20and\x20parasympathetic\x20ganglia&nbsp;innervated\x20by\x20preganglionic\x20autonomic\x20nerves.\x20Therefore,\x20both\x20the\x20ganglia\x20have\x20cholinergic\x20transmission.&nbsp;</li>\x0a<li>The\x20primary\x20rapid\x20depolarization\x20is\x20brought\x20about\x20by\x20Nn\x20type\x20of\x20nicotinic\x20cholinergic\x20receptors.</li>\x0a<li>Subsidiary\x20receptors\x20like\x20M1,\x20M2,\x20adrenergic,\x20dopaminergic\x20can\x20modulate\x20the\x20primary\x20response.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x464),'choices':[{'id':0x1,'text':_0x5da439(0x2bf)},{'id':0x2,'text':_0x5da439(0x2ac)},{'id':0x3,'text':'Mirabegron'},{'id':0x4,'text':_0x5da439(0x2d6)}],'correct_choice_id':0x3,'solution':_0x5da439(0x2ce),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Cevimeline\x20is\x20a\x20muscarinic\x20agonist\x20with\x20high\x20affinity\x20to','choices':[{'id':0x1,'text':_0x5da439(0x3ee)},{'id':0x2,'text':_0x5da439(0x30b)},{'id':0x3,'text':'M3\x20receptors'},{'id':0x4,'text':_0x5da439(0x247)}],'correct_choice_id':0x3,'solution':_0x5da439(0x2f2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x37a),'choices':[{'id':0x1,'text':'Adrenaline'},{'id':0x2,'text':_0x5da439(0x46a)},{'id':0x3,'text':_0x5da439(0x36f)},{'id':0x4,'text':'Dopamine'}],'correct_choice_id':0x1,'solution':'<p>The\x20vasomotor\x20reversal\x20of\x20Dale\x20is\x20seen\x20with\x20<strong>adrenaline</strong>\x20when\x20an\x20alpha\x20blocker\x20like<strong>\x20</strong>phentolamine\u00a0has\x20been\x20previously\x20administered.</p>\x0a<p>Rapid\x20IV\x20injection\x20of\x20adrenaline\x20produces\x20a\x20marked\x20increase\x20in\x20both\x20systolic\x20as\x20well\x20as\x20diastolic\x20BP.\x20This\x20occurs\x20because\x20at\x20<strong>high\x20concentrations\x20α\x20response</strong>\x20predominates\x20and\x20<strong>vasoconstriction</strong>\x20occurs.\x20As\x20the\x20concentration\x20<strong>declines</strong>,\x20adrenaline\x20is\x20not\x20able\x20to\x20act\x20on\x20α\x20receptors\x20but\x20continues\x20to\x20act\x20on<strong>\x20β2\x20receptors</strong>.</p>\x0a<p>When\x20an\x20<strong>α\x20blocker</strong>\u00a0has\x20been\x20given\x20and\x20then\x20adrenaline\x20is\x20injected,\x20only\x20a\u00a0<strong>fall\x20in\x20BP\x20</strong>instead\x20of\x20an\x20initial\x20rise\u00a0is\x20seen,\x20an\x20effect\x20first\x20described\x20by\x20Dale\x20and\x20hence\x20called<strong>\x20vasomotor\x20reversal\x20of\x20Dale</strong>.\x20This\x20is\x20due\x20to\x20adrenaline\x27s\x20<strong>action\x20only\x20on\u00a0β2\x20receptors</strong>,\x20which\x20are\x20not\x20blocked\x20by\x20phentolamine.</p>\x0a<p><strong>Noradrenaline</strong>\x20and\x20<strong>dopamine</strong>\x20<strong>lack\x20beta\x202\x20action,</strong>\x20and\x20vasomotor\x20reversal\x20of\x20the\x20Dale\x20phenomenon\x20is\x20not\x20seen\x20with\x20them.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x2c7),'choices':[{'id':0x1,'text':_0x5da439(0x37d)},{'id':0x2,'text':_0x5da439(0x422)},{'id':0x3,'text':_0x5da439(0x2a5)},{'id':0x4,'text':_0x5da439(0x265)}],'correct_choice_id':0x4,'solution':_0x5da439(0x241),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x217),'choices':[{'id':0x1,'text':_0x5da439(0x31c)},{'id':0x2,'text':'Epsilon\x20amino\x20caproic\x20acid'},{'id':0x3,'text':'Heparin'},{'id':0x4,'text':'Protamine'}],'correct_choice_id':0x2,'solution':_0x5da439(0x1d1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x18d),'choices':[{'id':0x1,'text':_0x5da439(0x170)},{'id':0x2,'text':_0x5da439(0x393)},{'id':0x3,'text':_0x5da439(0x3a7)},{'id':0x4,'text':'Bronchoconstriction'}],'correct_choice_id':0x3,'solution':_0x5da439(0x3d9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x208),'choices':[{'id':0x1,'text':_0x5da439(0x1b9)},{'id':0x2,'text':_0x5da439(0x46e)},{'id':0x3,'text':'Topical\x20carbonic\x20anhydrase\x20inhibitors'},{'id':0x4,'text':_0x5da439(0x348)}],'correct_choice_id':0x2,'solution':_0x5da439(0x389),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x19f),'choices':[{'id':0x1,'text':_0x5da439(0x1d3)},{'id':0x2,'text':_0x5da439(0x32b)},{'id':0x3,'text':_0x5da439(0x3ad)},{'id':0x4,'text':_0x5da439(0x429)}],'correct_choice_id':0x2,'solution':'<p>The\x20history\x20of&nbsp;<strong>claudication\x20pain&nbsp;</strong>suggests\x20a\x20likely\x20diagnosis\x20of\x20<strong>peripheral\x20vascular\x20disease</strong>\x20and\x20<strong>cilostazol</strong>\x20is\x20the\x20<strong>phosphodiesterase\x20inhibitor</strong>\x20that\x20is\x20<strong>indicated</strong>\x20in\x20this\x20condition.</p>\x0a<p>Phosphodiesterase\x20(PDE)\x20is\x20an\x20enzyme\x20that\x20degrades\x20cyclic\x20nucleotides\x20intracellularly.\x20Therefore,\x20phosphodiesterase\x20inhibitors\x20increase\x20the\x20concentration\x20of\x20cyclic\x20nucleotides\x20(cAMP\x20and\x20cGMP).</p>\x0a<p>There\x20are\x20different\x20classes\x20of\x20phosphodiesterase\x20inhibitors\x20of\x20which\x20<strong>cilostazol</strong>\x20is\x20a\x20<strong>PDE-3\x20inhibitor</strong>.\x20It\x20increases\x20intracellular\x20cAMP\x20in\x20vascular\x20smooth\x20muscle\x20and\x20platelets\x20leading\x20to\x20vasodilatory\x20and\x20antiaggregatory\x20effects.\x20This\x20allows\x20patients\x20with\x20intermittent\x20claudication\x20to\x20have\x20<strong>better\x20walking\x20distance</strong>.&nbsp;</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Sildenafil</strong>\x20and\x20tadalafil\x20are\x20<strong>selective\x20PDE-5\x20inhibitor</strong>&nbsp;and\x20are\x20used\x20for\x20<strong>pulmonary\x20arterial\x20hypertension</strong>\x20and\x20<strong>erectile\x20dysfunction</strong>.</p>\x0a<p>Option\x20C:\x20<strong>Theophylline</strong>\x20is\x20a\x20<strong>non-specific\x20phosphodiesterase</strong>\x20<strong>inhibitor</strong>\x20that\x20causes\x20<strong>bronchodilatation</strong>\x20as\x20well\x20as\x20decreases\x20the\x20release\x20of\x20inflammatory\x20cytokines.\x20It\x20has\x20<strong>limited\x20use</strong>\x20in\x20the\x20management\x20of\x20asthma\x20due\x20to\x20various\x20side\x20effects.</p>\x0a<p>Option\x20D:\x20<strong>Milrinone</strong>\x20is\x20a\x20<strong>selective\x20PDE\x20-\x203\x20inhibitor</strong>\x20and\x20is\x20used\x20as\x20a\x20short-term\x20therapy\x20in\x20<strong>severe</strong>\x20or\x20<strong>refractory\x20congestive\x20heart\x20failure</strong>.&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x33b),'choices':[{'id':0x1,'text':_0x5da439(0x24b)},{'id':0x2,'text':_0x5da439(0x189)},{'id':0x3,'text':'Direct\x20renin\x20blocker'},{'id':0x4,'text':_0x5da439(0x41d)}],'correct_choice_id':0x4,'solution':_0x5da439(0x474),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x173),'choices':[{'id':0x1,'text':'Azithromycin'},{'id':0x2,'text':_0x5da439(0x1d0)},{'id':0x3,'text':_0x5da439(0x462)},{'id':0x4,'text':_0x5da439(0x2f9)}],'correct_choice_id':0x3,'solution':_0x5da439(0x344),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x365),'choices':[{'id':0x1,'text':'Enfuviritide'},{'id':0x2,'text':_0x5da439(0x1e6)},{'id':0x3,'text':_0x5da439(0x35c)},{'id':0x4,'text':_0x5da439(0x460)}],'correct_choice_id':0x2,'solution':_0x5da439(0x3b0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x16d),'choices':[{'id':0x1,'text':'Cefazolin\x20is\x20a\x20first\x20generation\x20parenteral\x20cephalosporin'},{'id':0x2,'text':'Cefoperazone\x20has\x20anti-pseudomonal\x20activity'},{'id':0x3,'text':'Cefixime\x20has\x20poor\x20activity\x20against\x20Staph\x20aureus'},{'id':0x4,'text':_0x5da439(0x274)}],'correct_choice_id':0x4,'solution':_0x5da439(0x220),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x3dd),'choices':[{'id':0x1,'text':_0x5da439(0x38b)},{'id':0x2,'text':_0x5da439(0x1e1)},{'id':0x3,'text':_0x5da439(0x36f)},{'id':0x4,'text':_0x5da439(0x2c9)}],'correct_choice_id':0x3,'solution':_0x5da439(0x2e5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x45e),'choices':[{'id':0x1,'text':_0x5da439(0x449)},{'id':0x2,'text':_0x5da439(0x199)},{'id':0x3,'text':_0x5da439(0x18b)},{'id':0x4,'text':_0x5da439(0x169)}],'correct_choice_id':0x3,'solution':'<p>Nilotinib\x20is\x20an\x20inhibitor\x20of\x20BCR-ABL\x20tyrosine\x20kinase.</p>\x0a<p>BCR-ABL\x20tyrosine\x20kinase\x20inhibitors</p>\x0a<ul>\x0a<li>Imatinib</li>\x0a<li>Dasatinib</li>\x0a<li>Nilotinib</li>\x0a</ul>\x0a<p>Gefitinib\x20and\x20erlotinib\x20competitively\x20inhibits\x20ATP\x20binding\x20at\x20the\x20active\x20site\x20of\x20epidermal\x20growth\x20factor\x20receptor\x20(EGFR)\x20tyrosine\x20kinase\x20(options\x20a\x20and\x20b).\x20Afatinib\x20binds\x20covalently\x20to\x20EGFR\x20and\x20other\x20related\x20tyrosine\x20kinase\x20receptors\x20and\x20cause\x20irreversible\x20inhibition\x20(option\x20d).</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x205),'choices':[{'id':0x1,'text':_0x5da439(0x285)},{'id':0x2,'text':'Spirinolactone'},{'id':0x3,'text':_0x5da439(0x258)},{'id':0x4,'text':'Triamterene'}],'correct_choice_id':0x3,'solution':_0x5da439(0x210),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x1f7),'choices':[{'id':0x1,'text':_0x5da439(0x268)},{'id':0x2,'text':_0x5da439(0x2cd)},{'id':0x3,'text':_0x5da439(0x2f1)},{'id':0x4,'text':_0x5da439(0x264)}],'correct_choice_id':0x3,'solution':_0x5da439(0x36a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20following\x20acid-base\x20abnormality\x20is\x20least\x20likely\x20to\x20be\x20associated\x20with\x20salicylate\x20use\x20at\x20therapeutic\x20or\x20toxic\x20doses','choices':[{'id':0x1,'text':_0x5da439(0x335)},{'id':0x2,'text':_0x5da439(0x451)},{'id':0x3,'text':'Metabolic\x20acidosis'},{'id':0x4,'text':_0x5da439(0x45a)}],'correct_choice_id':0x2,'solution':_0x5da439(0x3ef),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20NSAIDs\x20can\x20commonly\x20cause\x20NSAID\x20induced\x20nephropathy?','choices':[{'id':0x1,'text':'Phenacetin'},{'id':0x2,'text':_0x5da439(0x300)},{'id':0x3,'text':_0x5da439(0x29b)},{'id':0x4,'text':_0x5da439(0x261)}],'correct_choice_id':0x1,'solution':'<p>Phenacetin,\x20a\x20para-amino\x20phenal\x20derivative\x20was\x20introduced\x20in\x201887\x20and\x20was\x20used\x20extensively\x20therafter.\x20<strong>It\x20was\x20subsequently\x20withdrawn\x20due\x20to\x20its\x20association\x20with\x20analgesic\x20abuse\x20nephropathy</strong>.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x2d2),'choices':[{'id':0x1,'text':_0x5da439(0x39c)},{'id':0x2,'text':_0x5da439(0x34f)},{'id':0x3,'text':_0x5da439(0x3d2)},{'id':0x4,'text':_0x5da439(0x286)}],'correct_choice_id':0x4,'solution':'<p><strong>Rupatadine</strong>\x20is\x20an\x20antihistaminic\x20drug\x20that\x20has\x20additional<strong>\x20platelet\x20activating</strong>\x20<strong>factor</strong>\x20<strong>antagonistic\x20property&nbsp;</strong>and\x20is\x20indicated\x20in\x20allergic\x20rhinitis.</p>\x0a<p>Platelet-activating\x20factor\x20(PAF)&nbsp;is&nbsp;involved\x20in\x20the\x20pathophysiology\x20of\x20allergic\x20rhinitis,\x20asthma,\x20and\x20anaphylaxis.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x2a8),'choices':[{'id':0x1,'text':_0x5da439(0x222)},{'id':0x2,'text':_0x5da439(0x166)},{'id':0x3,'text':_0x5da439(0x262)},{'id':0x4,'text':_0x5da439(0x2f4)}],'correct_choice_id':0x4,'solution':_0x5da439(0x332),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x3c7),'choices':[{'id':0x1,'text':'Altered\x20metabolism\x20of\x20vitamin\x20D'},{'id':0x2,'text':'Altered\x20metabolism\x20of\x20vitamin\x20K'},{'id':0x3,'text':_0x5da439(0x36f)},{'id':0x4,'text':'Direct\x20action\x20on\x20parathyroid\x20glands'}],'correct_choice_id':0x3,'solution':'<ul>\x0a<li><strong>Osteomalacia\x20due\x20to\x20phenytoin\x20use\x20is\x20attributed\x20to\x20both\x20alteration\x20in\x20vitamin\x20D\x20and\x20vitamin\x20K\x20metabolism.</strong></li>\x0a</ul>\x0a<ul>\x0a<li>Alteration\x20in\x20vitamin\x20D\x20metabolism\x20and\x20the\x20attendant\x20inhibition\x20in\x20intestinal\x20reabsorption\x20of\x20Ca<sup>2+</sup>\x20contributes\x20to\x20hypocalcemia\x20and\x20osteomalacia.</li>\x0a</ul>\x0a<ul>\x0a<li>The\x20increase\x20in\x20vitamin\x20K\x20metabolism\x20reduces\x20the\x20concentration\x20of\x20vitamin\x20K-dependent\x20proteins\x20that\x20are\x20important\x20for\x20normal\x20Ca<sup>2+</sup>\x20metabolism\x20in\x20bones.\x20This\x20is\x20the\x20reason\x20why\x20the\x20osteomalacia\x20due\x20to\x20phenytoin\x20is\x20not\x20always\x20ameliorated\x20by\x20the\x20administration\x20of\x20vitamin\x20D.</li>\x0a<li>Gamma\x20carboxylation\x20of\x20osteocalcin\x20and\x20other\x20important\x20activities\x20in\x20bone\x20requires\x20vitamin\x20K.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20a\x20carbamazepine\x20analogue\x20that\x20has\x20an\x20advantage\x20of\x20once\x20daily\x20dosing?','choices':[{'id':0x1,'text':_0x5da439(0x32a)},{'id':0x2,'text':_0x5da439(0x2f0)},{'id':0x3,'text':_0x5da439(0x45c)},{'id':0x4,'text':'Licarbazepine'}],'correct_choice_id':0x2,'solution':_0x5da439(0x19a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5da439(0x1ae),'choices':[{'id':0x1,'text':_0x5da439(0x1c1)},{'id':0x2,'text':_0x5da439(0x38c)},{'id':0x3,'text':_0x5da439(0x428)},{'id':0x4,'text':'Thiamine'}],'correct_choice_id':0x1,'solution':_0x5da439(0x3e1),'explanation_video':'','question_images':[],'explanation_images':[_0x5da439(0x2f7)]},{'text':_0x5da439(0x2a7),'choices':[{'id':0x1,'text':_0x5da439(0x1e2)},{'id':0x2,'text':'Cimetidine'},{'id':0x3,'text':_0x5da439(0x3c5)},{'id':0x4,'text':_0x5da439(0x2e0)}],'correct_choice_id':0x2,'solution':_0x5da439(0x223),'explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x5da439(0x37e);const quizFilename=_0x5da439(0x333);let hierarchy=[_0x5da439(0x28b),_0x5da439(0x187),_0x5da439(0x380)];if(window[_0x5da439(0x3c9)][_0x5da439(0x260)]['endsWith'](_0x5da439(0x1f8))){const customData=JSON[_0x5da439(0x3fe)](localStorage[_0x5da439(0x280)]('customQuizData'));if(customData){const tIhyXb=_0x5da439(0x312)[_0x5da439(0x1c5)]('|');let qXgIuz=0x0;while(!![]){switch(tIhyXb[qXgIuz++]){case'0':questionsData=customData[_0x5da439(0x40f)];continue;case'1':quizName=customData['name'];continue;case'2':hierarchy=customData[_0x5da439(0x19d)];continue;case'3':document[_0x5da439(0x431)](_0x5da439(0x416))['textContent']=questionsData[_0x5da439(0x39a)];continue;case'4':document['getElementById']('quizHierarchy')[_0x5da439(0x373)]=hierarchy[_0x5da439(0x346)](_0x5da439(0x31a));continue;case'5':document[_0x5da439(0x3c2)]=quizName+_0x5da439(0x28c);continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x5da439(0x25c),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x5da439(0x382)](),quizStartTime=Date[_0x5da439(0x382)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x5da439(0x39a)])['fill'](null)[_0x5da439(0x240)](()=>({'status':_0x5da439(0x43b),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x321903=_0x5da439,_0x47c69f={'ahCsY':'userHistory','VAtcx':_0x321903(0x1fb)};if(isQuizCompleted)return;const _0x23e84e=JSON[_0x321903(0x3fe)](localStorage[_0x321903(0x280)](_0x47c69f[_0x321903(0x322)]))||{};_0x23e84e[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x47c69f[_0x321903(0x3db)],'lastSeen':new Date()[_0x321903(0x2b2)]()},localStorage[_0x321903(0x437)](_0x47c69f[_0x321903(0x322)],JSON[_0x321903(0x427)](_0x23e84e));}function loadProgress(){const _0x37aca3=_0x5da439,_0x2c9f77={'pyhAz':'userHistory','dYVkL':_0x37aca3(0x3e3)},_0x1ec224=JSON['parse'](localStorage[_0x37aca3(0x280)](_0x2c9f77['pyhAz']))||{},_0x59e6ad=_0x1ec224[quizFilename];if(_0x59e6ad){const _0x58edcc=_0x2c9f77['dYVkL'][_0x37aca3(0x1c5)]('|');let _0xf67f34=0x0;while(!![]){switch(_0x58edcc[_0xf67f34++]){case'0':console[_0x37aca3(0x424)](_0x37aca3(0x283));continue;case'1':currentMode=_0x59e6ad[_0x37aca3(0x3a0)];continue;case'2':questionStates=_0x59e6ad[_0x37aca3(0x3de)];continue;case'3':currentQuestionIndex=_0x59e6ad[_0x37aca3(0x191)];continue;case'4':stats=_0x59e6ad[_0x37aca3(0x181)];continue;case'5':return!![];}break;}}return![];}function clearProgress(){const _0x334dd4=_0x5da439,_0x5f5046={'pMrzs':_0x334dd4(0x1b7)},_0x232390=JSON[_0x334dd4(0x3fe)](localStorage['getItem'](_0x5f5046[_0x334dd4(0x213)]))||{};_0x232390[quizFilename]&&(delete _0x232390[quizFilename],localStorage[_0x334dd4(0x437)](_0x5f5046[_0x334dd4(0x213)],JSON[_0x334dd4(0x427)](_0x232390)),console['log'](_0x334dd4(0x2e6)));}function markQuizAsCompleted(){const _0x59a2dc=_0x5da439,_0x3260e={'EHBXe':_0x59a2dc(0x1b7),'ohmDp':_0x59a2dc(0x396)},_0x4dfa86=JSON[_0x59a2dc(0x3fe)](localStorage[_0x59a2dc(0x280)](_0x3260e[_0x59a2dc(0x472)]))||{},_0x2d3952=questionsData[_0x59a2dc(0x39a)],_0x3371e5=stats[_0x59a2dc(0x421)]||0x0;_0x4dfa86[quizFilename]={'score':_0x3371e5,'total':_0x2d3952,'status':_0x3260e[_0x59a2dc(0x216)],'completedOn':new Date()[_0x59a2dc(0x2b2)]()},localStorage[_0x59a2dc(0x437)](_0x3260e[_0x59a2dc(0x472)],JSON[_0x59a2dc(0x427)](_0x4dfa86));}const urlParams=new URLSearchParams(window['location'][_0x5da439(0x381)]),startAt=parseInt(urlParams[_0x5da439(0x1f6)](_0x5da439(0x446))),resume=urlParams['get'](_0x5da439(0x2c3))===_0x5da439(0x432);function goBack(){const _0x5383e3=_0x5da439,_0x362c13={'JCFKS':function(_0x56f3ca){return _0x56f3ca();}};if(!isQuizCompleted)_0x362c13[_0x5383e3(0x196)](saveProgress);window[_0x5383e3(0x3c9)][_0x5383e3(0x36c)]=document[_0x5383e3(0x3e6)]||_0x5383e3(0x167);}function selectMode(_0x35ae76){const _0x152b23=_0x5da439;currentMode=_0x35ae76,document[_0x152b23(0x431)](_0x152b23(0x3fa))['style'][_0x152b23(0x38f)]=_0x152b23(0x27b),initializeQuiz();}function initializeQuiz(){const _0xd3298a=_0x5da439,_0x404903={'yAdGf':function(_0x486077){return _0x486077();},'AHHYH':'bookmarkBtn','GCZpo':function(_0x2f2591,_0x1c8f99){return _0x2f2591===_0x1c8f99;},'HPIgk':_0xd3298a(0x3d0),'lQBXg':'timed_exam','gMDnS':_0xd3298a(0x2b3),'TvcFy':'block','ltBlO':_0xd3298a(0x303),'IdgSg':_0xd3298a(0x27b),'LkgId':_0xd3298a(0x395),'JBsYh':'submitSection','xPkht':_0xd3298a(0x1a1),'qbccc':function(_0x81d2a0,_0x1d2566){return _0x81d2a0===_0x1d2566;},'qkuLo':_0xd3298a(0x473),'AkAQq':function(_0x4f244c,_0x3ec989){return _0x4f244c===_0x3ec989;},'sLVSm':_0xd3298a(0x30d),'FmXdI':_0xd3298a(0x403),'JXYzg':function(_0x1c496d,_0x4c829b){return _0x1c496d(_0x4c829b);},'RAWLV':function(_0x20c60a,_0x329306){return _0x20c60a<_0x329306;},'tPlhN':function(_0x3dd38a,_0x1de9d1){return _0x3dd38a!==_0x1de9d1;},'vUFRL':_0xd3298a(0x478),'kLfeb':function(_0xc0c6db){return _0xc0c6db();},'XjHmd':function(_0x35c9f5){return _0x35c9f5();},'umLSP':function(_0x1e1c74){return _0x1e1c74();}};quizStartTime=Date[_0xd3298a(0x382)]();const _0x461bb8=document[_0xd3298a(0x431)](_0x404903['AHHYH']),_0x1b8f97=document[_0xd3298a(0x431)](_0xd3298a(0x2f8)),_0x1b3f8e=document[_0xd3298a(0x431)]('testModeReviewLegend'),_0x3c7bd6=_0x404903[_0xd3298a(0x405)](currentMode,_0x404903[_0xd3298a(0x339)])||currentMode===_0x404903[_0xd3298a(0x3a4)];document[_0xd3298a(0x431)](_0x404903[_0xd3298a(0x471)])[_0xd3298a(0x2be)][_0xd3298a(0x38f)]=_0x3c7bd6?_0xd3298a(0x27b):_0x404903[_0xd3298a(0x397)],document['getElementById'](_0x404903[_0xd3298a(0x22c)])[_0xd3298a(0x2be)][_0xd3298a(0x38f)]=_0x3c7bd6?_0x404903['IdgSg']:_0x404903[_0xd3298a(0x397)],document[_0xd3298a(0x431)](_0x404903['LkgId'])['style'][_0xd3298a(0x38f)]=_0x3c7bd6?_0x404903[_0xd3298a(0x397)]:_0x404903['IdgSg'],document[_0xd3298a(0x431)](_0x404903[_0xd3298a(0x279)])[_0xd3298a(0x2be)][_0xd3298a(0x38f)]=_0x3c7bd6?_0x404903[_0xd3298a(0x397)]:_0x404903[_0xd3298a(0x36b)],_0x461bb8[_0xd3298a(0x2be)][_0xd3298a(0x38f)]=_0x3c7bd6?_0x404903[_0xd3298a(0x36b)]:_0x404903[_0xd3298a(0x168)],_0x1b8f97[_0xd3298a(0x2be)][_0xd3298a(0x38f)]=_0x3c7bd6?_0x404903['xPkht']:_0x404903['IdgSg'],_0x1b3f8e['style'][_0xd3298a(0x38f)]=_0x3c7bd6?_0x404903['xPkht']:_0x404903['IdgSg'],(_0x404903[_0xd3298a(0x1c7)](currentMode,_0x404903['qkuLo'])||_0x404903[_0xd3298a(0x1f4)](currentMode,_0x404903[_0xd3298a(0x3a4)]))&&document[_0xd3298a(0x431)](_0x404903['sLVSm'])[_0xd3298a(0x1e8)]['remove'](_0x404903[_0xd3298a(0x391)]),!_0x404903[_0xd3298a(0x26c)](isNaN,startAt)&&startAt>=0x0&&_0x404903[_0xd3298a(0x1ab)](startAt,questionsData[_0xd3298a(0x39a)])&&(_0x404903[_0xd3298a(0x1c4)](_0x404903[_0xd3298a(0x370)],'ridUd')?_0x404903[_0xd3298a(0x44d)](_0x34f23a):currentQuestionIndex=startAt),_0x404903[_0xd3298a(0x44d)](loadBookmarkedQuestions),_0x404903[_0xd3298a(0x447)](generateQuestionNav),_0x404903[_0xd3298a(0x2cf)](updateStats),_0x404903[_0xd3298a(0x25a)](displayQuestion);}function generateQuestionNav(){const _0x279511=_0x5da439,_0x3615ed={'KYSzY':_0x279511(0x2fe),'QkJBJ':function(_0x396c31,_0x47097d){return _0x396c31<_0x47097d;},'dKRRI':function(_0x1a5ab1,_0xb49e7){return _0x1a5ab1+_0xb49e7;},'ILzCJ':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','wuAyD':function(_0x829ac3){return _0x829ac3();}},_0x3b47e0=document['getElementById'](_0x3615ed[_0x279511(0x228)]);_0x3b47e0[_0x279511(0x3cf)]='';for(let _0x582eff=0x0;_0x3615ed[_0x279511(0x40c)](_0x582eff,questionsData['length']);_0x582eff++){const _0x812d7b=document[_0x279511(0x459)]('button');_0x812d7b[_0x279511(0x373)]=_0x3615ed[_0x279511(0x251)](_0x582eff,0x1),_0x812d7b[_0x279511(0x2ea)]=_0x3615ed[_0x279511(0x25e)],_0x812d7b[_0x279511(0x266)]=()=>jumpToQuestion(_0x582eff),_0x812d7b['id']=_0x279511(0x2b9)+_0x582eff,_0x3b47e0[_0x279511(0x337)](_0x812d7b);}_0x3615ed[_0x279511(0x435)](updateQuestionNav);}function _0x517b(){const _0x24e08d=['Which\x20of\x20the\x20following\x20is\x20not\x20useful\x20in\x20prophylaxis\x20of\x20migraine?','questionMedia','removeItem','KoVOo','Flavoxate','UuQhn','Lispro','trace','Arformoterol','An\x20infant\x20presents\x20with\x20the\x20following\x20features\x20shown\x20in\x20the\x20image\x20below.\x20On\x20examination,\x20microcephaly\x20and\x20hypoplasia\x20of\x20\x20distal\x20phalanges\x20are\x20also\x20found.\x20The\x20most\x20likely\x20medication\x20that\x20would\x20have\x20resulted\x20in\x20the\x20above\x20deformity\x20is','toISOString','statsBar','name','phlbV','DozGG','contains','Inhibition\x20of\x20aldehyde\x20dehydrogenase','navBtn_','Eptifibatide','</span><span>','AeKbC','Dyprz','style','Oxybutynin','nav-btn-answered','VyWoT','target','resume','reviewQuestionsContainer','IFiOB','bookmarkedQuestions','Which\x20of\x20the\x20following\x20has\x20higher\x20alpha\x201A\x20receptor\x20selective\x20blocking\x20activity?','qXXDZ','Methotrexate','Enalapril','<ul>\x0a<li>Km\x20of\x20the\x20enzyme\x20is\x20rate\x20constant\x20of\x20the\x20enzymatic\x20reaction\x20and\x20defined\x20as\x20the\x20substrate\x20concentration\x20at\x20which\x20the\x20velocity\x20reaches\x20half\x20of\x20the\x20maximum\x20(Vmax).</li>\x0a<li>Stimulation\x20of\x20an\x20enzyme\x20increases\x20its\x20affinity\x20for\x20the\x20substrate\x20resulting\x20in\x20lowering\x20of\x20rate\x20constant\x20(Km).\x20Eg:\x20Pyridoxine\x20acts\x20as\x20a\x20co-factor\x20and\x20stimulates\x20decarboxylase\x20activity.</li>\x0a</ul>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Type\x20of\x20enzyme\x20inhibition</td>\x0a<td>Km\x20value</td>\x0a</tr>\x0a<tr>\x0a<td>Enzyme\x20stimulation</td>\x0a<td>Decreased</td>\x0a</tr>\x0a<tr>\x0a<td>Enzyme\x20induction</td>\x0a<td>Unaltered</td>\x0a</tr>\x0a<tr>\x0a<td>Competitive\x20inhibition</td>\x0a<td>Increased</td>\x0a</tr>\x0a<tr>\x0a<td>Noncompetitive\x20inhibtion</td>\x0a<td>Unaltered</td>\x0a</tr>\x0a</tbody>\x0a</table>','aUEoU','Vitamin\x20D','<p>Mirabegron\x20is\x20a\x20<strong>beta\x203\x20agonist</strong>\x20that\x20is\x20indicated\x20for\x20the\x20treatment\x20of\x20overactive\x20bladder.</p>\x0a<p>Stimulation\x20of\x20beta\x203\x20receptors\x20in\x20detrusor\x20muscle\x20increases\x20the\x20bladder\x20capacity\x20and\x20provides\x20symptomatic\x20relief\x20in\x20overactive\x20bladder.</p>\x0a<p>Oxybutynin,\x20Solifenacin,\x20darifenacin\x20and\x20Fesoterodine\x20are\x20anticholinergics\x20that\x20are\x20used\x20in\x20the\x20treatment\x20of\x20overactive\x20bladder.</p>','XjHmd','Eltrombopag','1676634SfoZHn','Which\x20among\x20the\x20following\x20antihistaminic\x20drugs\x20has\x20additional\x20platelet-activating\x20factor\x20antagonistic\x20property?','AOScS','totalTime','explanation_audio_hin','Darifenacin','Cholestyramine','solution','(((.+)+)+)+$','SZRcF','sYDWE','answered','High\x20hepatic\x20extraction\x20ratio\x20is\x20not\x20seen\x20with','eDgiq','wMaIY','Nizatidine','notAttemptedResult','Glargine','explanation_video','Imipramine','<ul>\x0a<li>Cyclophosphamide\x20and\x20ifosfamide\x20release\x20a\x20urotoxic\x20metabolite\x20called\x20acrolein\x20in\x20high-dose\x20regimens.</li>\x0a<li>Acrolein\x20is\x20responsible\x20for\x20severe\x20hemorrhagic\x20cystitis.</li>\x0a<li>Mesna\x20or\x202-mercaptoethanesulfonate\x20prevents\x20hemorrhagic\x20cystitis\x20by\x20binding\x20acrolein.</li>\x0a<li>Leucovorin\x20is\x20helpful\x20in\x20mitigating\x20high\x20dose\x20methotrexate\x20toxicity\x20(option\x20d).</li>\x0a</ul>','Previous\x20progress\x20cleared.','hwaIp','replace','The\x20following\x20statement\x20is\x20not\x20true\x20about\x20sotalol','className','CNKft','IBAsQ','optionsContainer','gziop','<p>Ciprofloxacin\x20does\x20not\x20have\x20high\x20hepatic\x20extraction\x20ratio.</p>\x0a<p>Drugs\x20having\x20high\x20hepatic\x20extraction:</p>\x0a<ul>\x0a<li>Propranolol\x20(option\x20a)</li>\x0a<li>Morphine\x20(option\x20b)</li>\x0a<li>Pethidine</li>\x0a<li>Salbutamol</li>\x0a<li>Verapamil\x20(option\x20d)</li>\x0a<li>Glyeryl\x20trinitrate</li>\x0a</ul>\x0a<p>Clinical\x20correlate\x20for\x20drugs\x20with\x20high\x20hepatic\x20extraction:</p>\x0a<ul>\x0a<li>Oral\x20dose\x20is\x20very\x20high\x20when\x20compared\x20to\x20parenteral\x20dose\x20to\x20accommodate\x20high\x20hepatic\x20extraction.</li>\x0a<li>Oral\x20dose\x20has\x20to\x20be\x20reduced\x20in\x20liver\x20diseases.</li>\x0a</ul>','Eslicarbazepine\x20acetate','Insulin','<ul>\x0a<li>Cevimeline\x20is\x20a\x20muscarinic\x20agonist\x20that\x20has\x20high\x20affinity\x20to\x20M3\x20receptors\x20in\x20salivary\x20and\x20lacrimal\x20glands.</li>\x0a<li>It\x20has\x20fewer\x20side\x20effects\x20than\x20non-selective\x20pilocarpine.</li>\x0a<li>It\x20is\x20indicated\x20as\x20a\x20sialagogue\x20in\x20Sjogren&rsquo;s\x20syndrome.</li>\x0a</ul>','jKGgu','Pindolol','TYtwi','MXvTw','https://dhmbxeygs57ff.cloudfront.net/uploads/e161466fb10d429f81c37cb0bbc1f784x1280x1437.JPEG','markReviewBtn','Roxithromycin','ZRaKq','<p>The\x20IP\x20in\x20the\x20image\x20indicates\x20Indian\x20Pharmacopoeia</p>\x0a<ul>\x0a<li>Pharmacopoeia\x20contains\x20the\x20description\x20of\x20chemical\x20structure,\x20assay\x20methods,\x20solubility,\x20standards\x20of\x20purity\x20and\x20other\x20information\x20regarding\x20manufacturing\x20of\x20medicines.</li>\x0a<li>They\x20are\x20useful\x20to\x20drug\x20manufacturers\x20and\x20regulatory\x20authorities.\x20It\x20indicates\x20that\x20the\x20standards\x20present\x20in\x20the\x20mentioned\x20pharmacopoeia\x20are\x20followed.</li>\x0a</ul>\x0a<p>Examples\x20of\x20pharmacopoeia:</p>\x0a<ul>\x0a<li>IP:\x20Indian\x20Pharmacopoeia</li>\x0a<li>BP:\x20British\x20Pharmacopoeia</li>\x0a<li>USP:\x20United\x20States\x20Pharmacopoeia</li>\x0a</ul>','DvyGe','Incorrect','questionNav','fOwMm','Phenylbutazone','ujYWS','KjeQE','studyModeLegend','Hypocalcemia\x20is\x20seen\x20more\x20commonly\x20with','Gastrointestinal\x20disturbances','timed_exam','quizSidebar','disabled','fJIxK','scoreCircle','M2\x20receptors','CQYxM','timerContainer','bylhr','loadSource','xJKNk','GJCDR','0|1|2|5|3|4','YxPqo','pRluQ','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','preventDefault','Tirofiban','Dpwho','TwIcZ','\x20>\x20','div','Streptokinase','XNFXb','bhIlK','qDFVS','TVXAh','cvsWG','ahCsY','addEventListener','WBrhf','Which\x20of\x20the\x20following\x20is\x20the\x20first\x20FDA\x20approved\x20drug\x20for\x20obsessive-compulsive\x20disorder?','red','Vincristine','Ziwsb','Inhibits\x20enzyme\x205\x20alpha\x20reductase','Oxcarbezepine','Cilostazol','Increased\x20LDL-C','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','lEhiQ','QxBCb','bookmarkBtn','SKflv','<p><strong>Beta\x20blockers\x20having\x20intrinsic\x20sympathomimetic\x20activity\x20like\x20pindolol\x20is\x20not\x20effective\x20in\x20prophylaxis\x20of\x20migraine</strong>.</p>\x0a<p>Non-selective\x20blockers\x20like\x20propranolol\x20and\x20timolol\x20and\x20cardioselective\x20blockers\x20like\x20metoprolol,\x20atenolol\x20are\x20effective\x20in\x20prophylaxis\x20of\x20migraine.</p>','pharmacology-st-1-a3e27432.html','ZgQtY','Respiratory\x20alkalosis','rQiNK','appendChild','dataset','HPIgk','green','Sacubitril\x20is\x20a/an','yGNnu','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','Bookmarked','LamxW','vyQzY','qMxjE','QHBNM','daiRl','<ul>\x0a<li>Fidaxomicin\x20is\x20a\x20narrow\x20spectrum\x20macrocyclic\x20antibacterial\x20active\x20against\x20Clostridium\x20difficile.</li>\x0a<li>Like\x20macrolides\x20(14/15\x20memebered\x20ring),\x20fidaxomicin\x20has\x20a\x20large\x20lactone\x20ring\x20consisting\x20of\x2018\x20membered\x20ring.\x20But\x20the\x20mechanism\x20of\x20action\x20is\x20different.</li>\x0a<li>It\x20is\x20bactericidal\x20and\x20acts\x20by\x20inhibiting\x20protein\x20synthesis\x20through\x20blockade\x20of\x20RNA\x20polymerase.</li>\x0a<li>It\x20is\x20indicated\x20in\x20the\x20treatment\x20of\x20Clostridium\x20difficile\x20associated\x20diarrhea\x20especially\x20in\x20recurrent\x20cases.</li>\x0a</ul>','warn','join','tUdaD','Systemic\x20carbonic\x20anhydrase\x20inhibitors','StSAd','ccmWq','ArrowRight','Not\x20Attempted','filter','5mRZqax','Cetirizine','info','Which\x20of\x20the\x20following\x20is\x20not\x20a\x20long\x20acting\x20beta\x202\x20agonist\x20(LABA)?','mapmC','T-type\x20calcium\x20channels\x20are\x20blocked\x20by','SkEyT','application/vnd.apple.mpegurl','AEfvE','explanation_audio_eng','uucSl','BHEPD','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','IJxjg','Lopinavir','Clomipramine','fCMUN','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','Phenytoin','submitSection','correctResult','LJQdf','Selegiline','Which\x20of\x20the\x20following\x20drugs\x20blocks\x20the\x20binding\x20of\x20gp120\x20HIV\x20protein\x20to\x20the\x20CCR5\x20receptor?','Bevacizumab','Option\x20','hpnPO','{}.constructor(\x22return\x20this\x22)(\x20)','<p><strong>Insulin</strong>\x20receptors\x20belong\x20to\x20the\x20class\x20of<strong>\x20trans-membrane</strong>\x20enzyme-linked\x20receptors.</p>\x0a<p><strong>Transmembrane\x20enzyme-linked\x20receptors\x20</strong>consist\x20of\x20a<strong>&nbsp;</strong>large\x20extracellular\x20ligand-binding\x20domain.\x20It\x20is\x20connected\x20to\x20an\x20intracellular\x20subunit\x20having\x20enzymatic\x20property\x20through\x20a\x20single\x20transmembrane\x20helical\x20peptide\x20chain.\x20The\x20enzyme\x20on\x20the\x20cytosolic\x20side\x20is\x20usually\x20a\x20<strong>protein\x20kinase</strong>\x20(tyrosine)\x20or\x20<strong>membrane-bound\x20GC&nbsp;</strong>(guanylyl\x20cyclase).</p>\x0a<p>Physiological\x20ligands\x20for\x20transmembrane\x20enzyme-linked\x20receptors\x20are\x20mostly\x20growth\x20factors\x20and\x20chemokines.\x20Other\x20receptors\x20belonging\x20to\x20this\x20class\x20include:</p>\x0a<ul>\x0a<li><strong>Receptor\x20tyrosine\x20kinases\x20-&nbsp;</strong>Growth\x20factors\x20(PDGF,\x20EGF,\x20VEGF);\x20insulin</li>\x0a</ul>\x0a<ul>\x0a<li><strong>Membrane-bound\x20GC\x20-&nbsp;</strong>Natriuretic\x20peptides</li>\x0a</ul>\x0a<ul>\x0a<li><strong>Receptor\x20serine-threonine\x20kinases\x20-&nbsp;</strong>TGF-&beta;&nbsp;</li>\x0a</ul>\x0a<p>Thyroid\x20hormones,\x20vitamin\x20D,\x20and\x20steroids\x20act\x20via\x20intracellular\x20receptors.&nbsp;</p>','IdgSg','href','UCTsa','615160LECGqZ','Both\x20a\x20and\x20b','vUFRL','xqPjH','floor','textContent','OlEXQ','RCByJ','BlXhO','EqJkD','pWZaG','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','The\x20“Vasomotor\x20reversal\x20of\x20Dale”\x20phenomenon\x20is\x20seen\x20with\x20which\x20of\x20the\x20following\x20drugs?','Industrial\x20production','rQCyy','Prazosin','Pharmacology\x20St\x201','choices','Year\x202017\x20-\x2018','search','now','KlMEP','QvmGd','totalAttempted','nLTuY','Torsades\x20de\x20pointes\x20is\x20a\x20common\x20side\x20effect','GglJe','<p>Topical\x20PGF2\x20alpha\x20analogs\x20are\x20associated\x20with\x20hypertrichosis\x20of\x20eyelashes.</p>\x0a<p>Bimatoprost\x20is\x20used\x20in\x20the\x20topical\x20treatment\x20of\x20eyelash\x20hypotrichosis.</p>\x0a<p>Adverse\x20effects\x20of&nbsp;\x20topical\x20PGF2\x20alpha\x20analogs:</p>\x0a<ul>\x0a<li>Eyelash\x20hypertrichosis</li>\x0a<li>Iris\x20pigmentation</li>\x0a<li>Macular\x20edema</li>\x0a<li>Blurred\x20vision</li>\x0a</ul>','Mark\x20for\x20Review','Cyclophosphamide','Tyrptophan','customQuizData','3|1|5|4|2|0','display','TmxDW','FmXdI','goqto','Increased\x20wakefulness','vEjvl','testModeLegend','completed','TvcFy','lPZUc','accuracyScore','length','gGZMY','Fexofenadine','SYxsI','https://dhmbxeygs57ff.cloudfront.net/uploads/3c0ca949b982482ba2d9b8bcd800284ax800x500.PNG','solutionVideo','currentMode','Cholinergic\x20in\x20parasympathetic,\x20dopaminergic\x20in\x20sympathetic','GvlxD','WMFlg','lQBXg','VpBhl','pwmdh','Decreased\x20H1\x20mediated\x20gastrin\x20secretion','YNjkP','4639554HvrcoL','closest','reduce','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','Theophylline','totalQuestionsResult','oCHIe','<p><strong>Maraviroc</strong>\x20<strong>blocks</strong>\x20HIV\x20envelope\x20protein\x20<strong>gp120\x20</strong>from<strong>\x20binding\x20to\x20the\x20CCR5\x20receptor</strong>.&nbsp;</p>\x0a<p>During\x20the\x20entry\x20of\x20the\x20HIV\x20virus\x20into\x20the\x20host\x20cell,\x20<strong>gp120\x20anchors\x20the\x20virion</strong>\x20to\x20the\x20host\x20cell\x20<strong>by\x20binding\x20to\x20CD4</strong>.\x20Further,\x20<strong>gp120\x20binds\x20to\x20CCR5</strong>\x20chemokine\x20receptors\x20<strong>to\x20stabilize</strong>\x20the\x20entire\x20complex.\x20<strong>Gp41</strong>\x20then\x20mediates\x20the\x20<strong>fusion\x20of\x20the\x20viral\x20membrane\x20with\x20the\x20cell\x20membrane</strong>\x20of\x20the\x20target\x20cell.&nbsp;<strong>Maraviroc</strong>\x20is\x20an\x20<strong>entry\x20inhibitor</strong>\x20that\x20is\x20used\x20for\x20the\x20treatment\x20of\x20HIV.&nbsp;<strong>Maraviroc</strong>\x20<strong>binds\x20to\x20CCR5</strong>\x20receptors\x20and\x20<strong>prevents\x20viral\x20entry</strong>\x20into\x20the\x20cell.&nbsp;</p>\x0a<p><strong>Enfuvirtide</strong>\x20(option\x20A)\x20is\x20another\x20<strong>entry\x20inhibito</strong>r\x20that\x20<strong>binds\x20to</strong>\x20certain\x20domains\x20of\x20<strong>gp41\x20HIV\x20protein</strong>\x20and\x20<strong>prevents\x20membrane\x20fusion</strong>\x20and\x20viral\x20entry\x20into\x20the\x20cell.\x20It\x20is\x20the\x20<strong>only\x20antiretroviral\x20drug</strong>\x20that\x20is\x20<strong>given\x20parenterally</strong>\x20(subcutaneous\x20or\x20intravenous).&nbsp;</p>\x0a<p><strong>Lopinavir</strong>\x20(option\x20C)\x20is\x20a\x20<strong>protease\x20inhibitor</strong>.\x20This\x20class\x20of\x20drugs\x20<strong>inhibits\x20the\x20viral\x20protease</strong>\x20that\x20is\x20essential\x20for\x20conversion\x20of\x20the\x20inactive\x20protein\x20precursors\x20into\x20functional\x20proteins.</p>\x0a<p><strong>Raltegravir</strong>\x20(option\x20D)\x20is\x20an\x20<strong>integrase\x20inhibitor</strong>.\x20It\x20<strong>prevents</strong>\x20the\x20formation\x20of\x20covalent\x20bond&nbsp;&mdash;\x20and\x20thus\x20the\x20<strong>integration</strong>&nbsp;&mdash;\x20<strong>of</strong>\x20the\x20<strong>HIV\x20DNA\x20and\x20the\x20host\x20cell\x20DNA</strong>.</p>','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','Which\x20of\x20the\x20following\x20is\x20an\x20inhibitor\x20of\x20vasopressin\x20secretion?','Ncsjr','padStart','28929HfiAVe','<ul>\x0a<li>Ezetimibe\x20is\x20a\x20cholesterol\x20absorption\x20inhibitor.</li>\x0a<li>It\x20interferes\x20with\x20a\x20specific\x20cholesterol\x20transport\x20protein\x20(NPC1L1)\x20in\x20intestinal\x20mucosa\x20and\x20decreases\x20cholesterol\x20absorption.</li>\x0a<li>Cholestyramine\x20and\x20colesevelam\x20are\x20bile\x20acid\x20sequestrants.</li>\x0a<li>Saroglitazar\x20is\x20a\x20dual\x20PPAR\x20agonist\x20approved\x20for\x20diabetic\x20dyslipidemia\x20in\x20India.</li>\x0a</ul>','nav-btn-incorrect','IIHrL','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','<p>Ethosuximide\x20is\x20an\x20antiepileptic\x20that\x20acts\x20through\x20selective\x20suppression\x20of\x20T-type\x20calcium\x20channels.\x20It\x20is\x20indicated\x20in\x20the\x20treatment\x20of\x20absence\x20seizures.</p>\x0a<p>Types\x20of\x20calcium\x20channels\x20and\x20their\x20blockers:</p>\x0a<ul>\x0a<li>L\x20type:\x20Verapamil,\x20diltiazem,\x20dihydropiridines</li>\x0a<li>T\x20type:\x20Flunarizine,\x20ethosuximide,\x20mibefradil</li>\x0a<li>N\x20type:\x20Gabapentin,\x20ziconotide</li>\x0a<li>P/Q\x20type:\x20Omega\x20agatoxin\x20IVa</li>\x0a<li>R\x20type:\x20SNX-482,\x20Omega\x20agatoxin\x20IIIa</li>\x0a</ul>','qHcBK','NbGiD','Phase\x200','remove','pVDMx','HXoNv','pkVzz','title','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','Ethanol','Famotidine','Recombinant\x20interleukin\x2011\x20that\x20is\x20used\x20in\x20thrombocytopenia\x20is','Osteomalacia\x20in\x20phenytoin\x20is\x20due\x20to:','click','location','QgxSq','questionReviewSection','TBDnD','WNTTB','3|0|5|4|2|1','innerHTML','test','KkSiX','Ebastine','attachMedia','VhxTC','strokeDashoffset','eOYkH','prevBtn','nWjAn','<p><strong>H3\x20receptors</strong>\x20are\x20predominantly\x20<strong>auto\x20receptors</strong>\x20that\x20<strong>decrease\x20histamine\x20release</strong>\x20and\x20<strong>antagonize\x20the\x20actions\x20of\x20histamine</strong>.</p>\x0a<p>Therefore,\x20H3\x20receptor\x20agonists\x20<strong>decrease\x20H1\x20mediated\x20gastrin\x20secretion</strong>.</p>\x0a<p><strong>H3\x20receptor\x20agonist\x20actions</strong>:</p>\x0a<ul>\x0a<li><strong>Negative\x20chronotropic\x20activity</strong>:\x20modulatory\x20activity\x20on\x20adrenergic\x20neuronal\x20terminals\x20resulting\x20in\x20decreased\x20NA\x20release\x20(option\x20a)</li>\x0a<li><strong>Sedation</strong>\x20due\x20to\x20decreased\x20histamine\x20release\x20(option\x20b)</li>\x0a<li><strong>Inhibition</strong>\x20<strong>of</strong>\x20histamine\x20induced<strong>\x20bronchoconstriction</strong>\x20(option\x20d)</li>\x0a</ul>','NSCuR','VAtcx','The\x20main\x20lipid\x20abnormality\x20associated\x20with\x20atypical\x20antipsychotics\x20use\x20is','Mesna\x20use\x20reduces\x20the\x20toxicity\x20associated\x20with\x20high\x20doses\x20of','questionStates','soAmL','kFLqH','<p>The\x20given\x20clinical\x20presentation\x20of\x20a\x20<strong>hypertensive\x20crisis</strong>\x20in\x20a\x20patient\x20on\x20<strong>MAO\x20inhibitor</strong>\x20therapy\x20is\x20suggestive\x20of\x20<strong>cheese\x20reaction</strong>,\x20which\x20is\x20seen\x20after\x20consumption\x20of\x20foods\x20rich\x20in<strong>&nbsp;tyramine\x20</strong>(beer).</p>\x0a<p>Tyramine\x20is\x20an\x20indirect\x20<strong>sympathomimetic</strong>.\x20It\x20induces\x20the\x20release\x20of\x20catecholamines\x20from\x20the\x20neurons.\x20Tyramine\x20can\x20be\x20produced\x20in\x20high\x20concentrations\x20in\x20<strong>protein-rich\x20foods</strong>\x20by\x20decarboxylation\x20of\x20tyrosine\x20during\x20fermentation.</p>\x0a<p>Normally\x20tyramine\x20is\x20<strong>inactivated</strong>\x20when\x20taken\x20orally\x20because\x20it\x20is\x20readily\x20metabolized\x20<strong>by\x20MAO</strong>\x20in\x20the\x20liver.\x20In\x20patients\x20who\x20are\x20on&nbsp;<strong>MAO\x20inhibitor\x20therapy</strong>,\x20the\x20tyramine\x20taken\x20in\x20the\x20diet\x20is\x20<strong>not\x20inactivated</strong>\x20and\x20results\x20in\x20its\x20<strong>increased\x20sympathomimetic\x20effect</strong>\x20resulting\x20in\x20elevated\x20blood\x20pressure,\x20termed\x20as\x20hypertensive\x20crisis\x20or\x20cheese\x20reaction.\x20Drug\x20of\x20choice\x20for\x20cheese\x20reaction\x20is\x20<strong>IV\x20phentolamine.</strong></p>\x0a<p>When\x20MAO\x20inhibitors\x20are\x20taken\x20along\x20with\x20SSRI\x20or\x20TCA,\x20it\x20results\x20in\x20<strong>serotonin\x20syndrome\x20</strong>due\x20to\x20the\x20overstimulation\x20of\x205HT\x20receptors.\x20The\x20clinical\x20features\x20are\x20a\x20triad\x20of:</p>\x0a<ol>\x0a<li><strong>Cognitive</strong>\x20effect\x20-\x20delirium,\x20coma</li>\x0a<li><strong>Autonomic</strong>\x20effects-\x20hypertension,\x20tachycardia</li>\x0a<li><strong>Somatic</strong>\x20effects-\x20myoclonus,\x20hyperreflexia,\x20tremors</li>\x0a</ol>','findIndex','2|4|3|1|0|5','Cangrelor','ffeHW','referrer','return\x20(function()\x20','JVEjx','Thiazide\x20diuretics','gQfgv','open','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','markReviewText','M1\x20receptors','<p><strong>Metabolic\x20alkalosis\x20</strong>is\x20<strong>least\x20likely</strong>\x20to\x20be\x20associated\x20with\x20salicylate\x20use\x20at\x20therapeutic\x20or\x20toxic\x20doses.<strong>&nbsp;</strong></p>\x0a<p>At&nbsp;therapeutic\x20doses:&nbsp;\x20Salicylates\x20stimulate\x20respiratory&nbsp;center\x20causing\x20a\x20fall\x20in\x20PCO<sub>2\x20</sub>leading\x20to&nbsp;<strong>respiratory\x20alkalosis</strong>.\x20This\x20is\x20compensated\x20by\x20increased\x20renal\x20bicarbonate\x20excretion.&nbsp;</p>\x0a<p>At\x20higher\x20(toxic)\x20doses:\x20Salicylates\x20directly\x20depress\x20the\x20respiration\x20preventing\x20the\x20washout\x20of\x20CO<sub>2</sub>&nbsp;causing\x20a\x20fall\x20in\x20blood\x20pH.\x20Since\x20the\x20concentration\x20of\x20HCO<sub>3</sub><sup>-</sup>\x20in\x20already\x20low\x20in\x20the\x20plasma\x20due\x20to\x20increased\x20renal\x20excretion,\x20it\x20leads\x20to\x20uncompensated&nbsp;<strong>respiratory\x20acidosis</strong>.</p>\x0a<p>Further,\x20salicylates\x20impair\x20renal\x20function\x20leading\x20to\x20accumulation\x20of\x20sulfuric\x20and\x20phosphoric\x20acids\x20and\x20accumulation\x20of\x20organic\x20acids\x20like\x20pyruvic,\x20lactic\x20and\x20acetoacetic\x20acid.&nbsp;This\x20together\x20leads\x20to\x20<strong>metabolic\x20acidosis</strong>.&nbsp;</p>','toString','incorrect','EbSHk','uClSL','Ezetimibe','currentQuestion','DOMContentLoaded','nBDlC','jgjJY','Idarucizumab','modeModal','anTUo','QcdYf','reload','parse','Desipramine','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','etBnE','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','hidden','Thfnc','GCZpo','Which\x20of\x20the\x20following\x20is\x20not\x20a\x20GPIIb/IIIa\x20inhibitor?','aOdkU','key','solutionContainer','vyYBQ','SDKoN','QkJBJ','Verapamil','constructor','questions','Inhibition\x20of\x20CYP2E1','sPnsX','incorrectResult','pZNPF','selectedAnswer','UpRAB','totalQuestions','rIXaY','EjErU','solutionText','eGcIc','<p>Atypical\x20antipsychotics\x20are\x20associated\x20with\x20dyslipidemia,\x20particularly\x20hypertriglyceridemia.</p>\x0a<p>Metabolic\x20abnormalities\x20associated\x20with\x20atypical\x20antipsychotics.</p>\x0a<ul>\x0a<li>Increased\x20weight</li>\x0a<li>Dyslipidemia</li>\x0a<li>New-onset\x20type\x202\x20DM</li>\x0a<li>Diabetic\x20ketoacidosis</li>\x0a</ul>\x0a<p>Atypical\x20agents\x20classified\x20according\x20to\x20their\x20metabolic\x20risk\x20potential</p>\x0a<ul>\x0a<li>Highest:\x20clozapine,\x20olanzapine</li>\x0a<li>Immediate:\x20quetiapine,\x20risperidone,\x20paliperidone</li>\x0a<li>Least:\x20Aripiprazole,\x20ziprasidone,\x20iloperidone,\x20asenapine</li>\x0a</ul>','quizHierarchy','Neprilysin\x20inhibitor','Increased\x20HDL-C','includes','<p>Clomipramine\x20is\x20a\x20tricyclic\x20antidepressant\x20that\x20was\x20the\x20first\x20approved\x20drug\x20for\x20obsessive-compulsive\x20disorder\x20(OCD).</p>\x0a<p>The\x20following\x20SSRIs\x20have\x20also\x20been\x20approved\x20by\x20the\x20US\x20FDA\x20or\x20use\x20in\x20OCD:</p>\x0a<ul>\x0a<li>Fluoxetine</li>\x0a<li>Fluvoxamine</li>\x0a<li>Paroxetine\x20(Paxil)</li>\x0a<li>Sertraline\x20(Zoloft)&nbsp;</li>\x0a<li>Citalopram</li>\x0a</ul>','correctAnswers','Tamsulosin','markedForReview','log','status','ArrowLeft','stringify','Threonine','Milrinone','QWnsB','width','fRmew','TaJyH','Bpliy','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','International\x20pharmaceuticals','getElementById','true','UXwRU','<ul>\x0a<li>Sotalol\x20is\x20a\x20non\x20selective\x20beta\x20blocker.</li>\x0a<li>It\x20has\x20additional\x20class\x20III\x20antiarrhythmic\x20properties\x20and\x20thus\x20prolongs\x20the\x20APD\x20as\x20well\x20as\x20the\x20QT\x20interval\x20(option\x20b).\x20So\x20it\x20has\x20propensity\x20to\x20cause\x20Torsades\x20de\x20pointes.\x20(option\x20d).</li>\x0a<li>Torsades\x20de\x20pointes\x20incidence\x20is\x20around\x201.5-2%\x20and\x20is\x20dose\x20dependent.</li>\x0a<li>Sotalol\x20is\x20a\x20lipid\x20insoluble\x20beta\x20blocker\x20and\x20thus\x20excreted\x20primarily\x20by\x20the\x20kidneys\x20(option\x20c).</li>\x0a<li>Other\x20lipid\x20insoluble\x20beta\x20blockers\x20are\x20atenolol\x20and\x20nadolol.</li>\x0a</ul>','wuAyD','EhWTG','setItem','ncoWM','Indian\x20pharmacopoeia','Complication\x20that\x20is\x20not\x20associated\x20with\x20metformin\x20use','not_attempted','dKnyw','matge','EcTOJ','1836285XYvdVN','VSApg','No\x20questions\x20available\x20for\x20this\x20quiz.','NTFoS','mRpkv','Correct','yHMNi','startAt','kLfeb','ZCkgp','Gefitinib','YACVT','progressBar','ZIKhl','yAdGf','brxTc','Which\x20of\x20the\x20following\x20is\x20not\x20a\x20prodrug?','correct_choice_id','Metabolic\x20alkalosis','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','wSWDK','solutionAudio','notAttempted','HpRmT','xCOmC','isSupported','createElement','Respiratory\x20acidosis','czliZ','Dacarbazine','iGCfF','BCR-ABL\x20tyrosine\x20kinase\x20inhibitor\x20is','Ethosuximide','Raltegravir','fwRVL','Fidaxomicin','FLBVP','Beta\x203\x20agonist\x20indicated\x20for\x20treatment\x20of\x20overactive\x20bladder','cKwjM','It\x20is\x20excreted\x20primarily\x20through\x20kidneys','question_audio','sTnTa','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','Noradrenaline','Which\x20of\x20the\x20following\x20is\x20a\x20direct\x20thrombin\x20inhibitor?','solutionImages','yBLby','Topical\x20PGF2\x20alpha\x20analogs','aIJHw','YEJJp','gMDnS','EHBXe','timed_study','<ul>\x0a<li>Sacubitril\x20is\x20a\x20neprilysin\x20inhibitor\x20indicated\x20for\x20the\x20management\x20of\x20CHF\x20along\x20with\x20valsartan,\x20an\x20AT1\x20receptor\x20antagonist\x20(option\x20b).</li>\x0a<li>The\x20combination\x20has\x20mortality\x20benefits\x20in\x20CHF\x20patients.</li>\x0a<li>Neprilysin\x20is\x20an\x20enzyme\x20responsible\x20for\x20the\x20breakdown\x20of\x20atrial\x20and\x20brain\x20natriuretic\x20peptide.\x20Inhibition\x20of\x20neprilysin\x20results\x20in\x20increased\x20natriuresis\x20and\x20other\x20effects\x20that\x20are\x20beneficial\x20for\x20CHF\x20patients.</li>\x0a</ul>','toLowerCase','nrFMv','qLeuY','ridUd','nvToM','Timolol','index.html','xPkht','Afatinib','Tolcapone','<div\x20class=\x22mt-4\x22><img\x20src=\x22','question_images','All\x20are\x20true\x20about\x20cephalosporins\x20except','apply','shPSf','Positive\x20chronotropic\x20effect','FlbNO','add','Macrocyclic\x20antibiotic\x20indicated\x20for\x20the\x20treatment\x20of\x20Clostridium\x20difficile\x20associated\x20diarrhea\x20is','VLxJn','toggle','fromCharCode','https://cdn1.dailyrounds.org/uploads/7011252c40d14672aa0ba62ab33b0c26.PNG','Dabigatran','Vitamin\x20B12\x20deficiency','The\x20following\x20side\x20effect\x20in\x20a\x20young\x20male\x20patient\x20can\x20be\x20due\x20to','push','HOcLr','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','xfeIs','zusrG','.option-button','stats','VrNBE','VBNWC','JiJtS','WaUDM','TIAkF','NEET\x20PG\x20Test\x20Series\x20Subject\x20Wise','Carbidopa','Angiotensin\x20receptor\x20blocker','questionText','Nilotinib','KoxzI','H3\x20receptor\x20agonists\x20exhibits','bZmpW','review-question\x20','kINjM','currentQuestionIndex','yBzws','gXNuu','tkwzm','getAttribute','JCFKS','<p>Dabigatran\x20is\x20an\x20oral\x20anticoagulant\x20that\x20inhibits\x20thrombin\x20directly.</p>\x0a<p>Oral\x20factor\x20Xa\x20inhibitors\x20(have\x20&ldquo;xa&rdquo;\x20in\x20their\x20names)</p>\x0a<ul>\x0a<li>Rivaroxaban</li>\x0a<li>Apixaban</li>\x0a<li>Edoxaban</li>\x0a</ul>\x0a<p>Idarucizumab\x20is\x20an\x20antidote\x20for\x20dabigatran.&nbsp;\x20It\x20is\x20a\x20monocloncal\x20antibody\x20against\x20dabigatran\x20that\x20binds\x20dabigatran\x20more\x20avidly\x20than\x20thrombin.</p>','endsWith','Erlotinib','<p><strong>Eslicarbazepine\x20acetate</strong>\x20is\x20an\x20analog\x20of\x20carbamazepine\x20that\x20has\x20the\x20advantage\x20of\x20<strong>once-daily</strong>\x20dosing.\x20It\x20is\x20a\x20<strong>prodrug</strong>\x20and\x20is\x20rapidly\x20converted\x20to\x20active\x20<strong>licarbazepine</strong>.</p>\x0a<p><strong>Oxcarbazepine</strong>\x20is\x20an\x20analog\x20of\x20carbamazepine\x20that\x20is\x20also\x20converted\x20to\x20licarbazepine.\x20Oxcarbazepine\x20does\x20not\x20have\x20the\x20advantage\x20of\x20once-daily\x20dosing\x20like\x20eslicarbazepine\x20acetate.</p>\x0a<p><strong>Dacarbazine</strong>\x20is\x20not\x20a\x20carbamazepine\x20analog\x20like\x20the\x20other\x20drugs\x20and\x20is\x20a\x20<strong>chemotherapy</strong>\x20medication\x20used\x20in\x20the\x20treatment\x20of\x20<strong>melanoma</strong>\x20and\x20<strong>Hodgkin\x27s\x20lymphoma.</strong></p>','eDGgA','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','hierarchy','ExXDX','A\x20patient\x20comes\x20with\x20complaints\x20of\x20claudication\x20pain\x20of\x20the\x20left\x20lower\x20limb\x20while\x20walking.\x20Which\x20of\x20the\x20following\x20phosphodiesterase\x20inhibitors\x20is\x20indicated\x20in\x20this\x20condition?','nwnMU','flex','JFQCm','querySelectorAll','RTgxM','Salmeterol','lICQZ','NEjgn','bpfBf','soUVF','525GbdkxI','RAWLV','\x22\x20data-src=\x22','console','A\x20college\x20student\x20on\x20MAO\x20inhibitor\x20therapy\x20for\x20depression\x20consumed\x20two\x20bottles\x20of\x20beer\x20during\x20a\x20party.\x20The\x20next\x20day\x20he\x20started\x20experiencing\x20severe\x20headache,\x20nausea,\x20and\x20vomiting.\x20He\x20was\x20taken\x20to\x20the\x20casualty\x20by\x20his\x20friends\x20where\x20his\x20BP\x20was\x20recorded\x20to\x20be\x20180/110mmHg.\x20Which\x20of\x20the\x20following\x20compounds\x20would\x20be\x20responsible\x20for\x20this\x20complication?','src','lswEC','questionIndex','nAzHN','nYYtd','BOxLe','<p>The\x20drug\x20that\x20corresponds\x20to\x20the\x20action\x20of\x20A\x20is\x20<strong>tolcapone</strong>.</p>\x0a<p>Tolcapone\x20is\x20an\x20<strong>anti-parkinsonism\x20drug</strong>\x20that\x20acts\x20by\x20<strong>inhibiting\x20COMT\x20enzyme&nbsp;</strong>and\x20is\x20an\x20<strong>adjuvant</strong>\x20to\x20<strong>levodopa-carbidopa</strong>\x20in\x20<strong>advanced\x20parkinsonism\x20</strong>with<strong>\x20motor\x20fluctuations</strong>.\x20It\x20acts\x20as\x20an\x20adjuvant\x20by\x20prolonging\x20the\x20half-life\x20of\x20levodopa.\x20COMT\x20inhibitors\x20are\x20used\x20to\x20smoothen\x20the\x20\x27wearing\x20off\x27\x20as\x20well\x20as\x20increase\x20the\x20\x27on\x27\x20time\x20and\x20decrease\x20the\x20\x27off\x27\x20time\x20and\x20thus\x20allowing\x20to\x20reduce\x20the\x20dose\x20of\x20levodopa.\x20Another\x20drug\x20in\x20the\x20same\x20class\x20is\x20<strong>entacapone</strong>.</p>\x0a<p>Parkinsonism\x20is\x20an\x20<strong>extrapyramidal\x20disorder</strong>\x20and\x20is\x20characterized\x20by\x20<strong>rigidity</strong>,\x20<strong>tremor</strong>,\x20and<strong>\x20hypokinesia</strong>.\x20It\x20occurs\x20due\x20to\x20degeneration\x20of\x20substantia\x20nigra\x20and\x20the\x20nigrostriatal\x20tract\x20causing\x20a\x20<strong>deficiency\x20</strong>of\x20<strong>dopamine</strong>.&nbsp;&nbsp;</p>\x0a<p>Other\x20options:</p>\x0a<p>Options\x20A\x20and\x20B:\x20<strong>Benserazide</strong>\x20and<strong>\x20carbidopa</strong>\x20are\x20<strong>peripheral\x20</strong>(extracerebral)<strong>\x20dopa\x20decarboxylase\x20inhibitors</strong>\x20and\x20do\x20not\x20penetrate\x20the\x20blood-brain\x20barrier\x20or\x20inhibit\x20the\x20conversion\x20of\x20levodopa\x20into\x20dopamine.&nbsp;</p>\x0a<p>Option\x20C:&nbsp;<strong>Selegiline</strong>\x20is\x20an\x20<strong>MAO</strong>-<strong>B\x20inhibitor\x20</strong>and\x20at\x20low\x20doses<strong>\x20retards\x20</strong>the<strong>\x20intracerebral\x20degradation\x20</strong>of<strong>\x20dopamine</strong>.</p>\x0a<p>The\x20image\x20below\x20shows\x20the\x20various\x20mechanisms\x20by\x20which\x20different\x20drugs\x20show\x20anti-parkinsonian\x20action.</p>','performanceModal','userHistory','correct','Topical\x20beta\x20blockers','Cimetidine','saMuC','acvKQ','It\x20prolongs\x20action\x20potential\x20duration\x20throughout\x20the\x20heart','not-attempted','correctCount','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','Tyramine','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','hYbpc','tPlhN','split','WKTvI','qbccc','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','Competitive\x20inhibition','BvztB','SEMjS','RFFjd','BIfJA','SgUxg','Infertility','Telithromycin','<ul>\x0a<li>Epsilon\x20amino\x20caproic\x20acid\x20binds\x20lysine-binding\x20site\x20of\x20plasmin\x20and\x20inhibits\x20plasmin-induced\x20fibrinolysis.</li>\x0a<li>Streptokinase\x20is\x20a\x20plasminogen\x20activator\x20that\x20results\x20in\x20fibrinolysis\x20(option\x20a).</li>\x0a<li>Heparin\x20is\x20an\x20anticoagulant,\x20whereas\x20protamine\x20is\x20an\x20antidote\x20to\x20heparin\x20(options\x20c\x20and\x20d).</li>\x0a</ul>','RaqCf','Sildenafil','Has\x20partial\x20agonist\x20and\x20antagonist\x20action\x20on\x20estrogen\x20receptors','Nicotine','kHGRF','vahPT','jSflm','<ul>\x0a<li><strong>Oprelvekin\x20is\x20a\x20recombinant\x20interleukin\x2011</strong>\x20preparation.</li>\x0a<li>It\x20stimulates\x20thrombopoiesis\x20and\x20is\x20indicated\x20in\x20prevention\x20of\x20thrombocytopenia\x20associated\x20with\x20antineoplastic\x20agents.</li>\x0a<li>Romiplostim\x20and\x20eltrombopag\x20are\x20thrombopoietin\x20receptor\x20agonist\x20that\x20are\x20used\x20in\x20chronic\x20immune\x20thrombocytopenia\x20(options\x20a\x20and\x20b).</li>\x0a</ul>','emvrZ','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','Physostigmine','xZDUx','border-green-500','Kktzc','Dihydropyridines','Ifosfamide','Ranitidine','TOeod','ANpkU','https://cdn1.dailyrounds.org/uploads/5551c804072f4c8e97a03c8423583cb6.JPEG','Maraviroc','tzRbe','classList','Decrease\x20in\x20Km\x20value\x20for\x20an\x20enzymatic\x20reaction\x20is\x20seen\x20with','<p><strong>Alirocumab</strong>\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20that<strong>\x20inhibits\x20PCSK9</strong>\x20that\x20is\x20used\x20in\x20<strong>familial\x20hypercholesterolemia</strong>.</p>\x0a<p><strong>PCSK9</strong>\x20is\x20a\x20serine\x20protease\x20that\x20<strong>causes\x20lysosomal\x20degradation\x20of\x20the\x20LDL\x20receptors</strong>\x20present\x20on\x20the\x20surface\x20of\x20the\x20hepatocytes.\x20<strong>Monoclonal\x20antibodies\x20directed\x20against\x20PCSK9</strong>\x20such\x20as\x20<strong>alirocumab</strong>\x20and\x20<strong>evolocumab</strong>\x20counter\x20this\x20and\x20<strong>cause\x20the\x20persistence\x20of\x20LDL\x20receptors</strong>\x20on\x20hepatocytes.\x20This\x20leads\x20to\x20<strong>more\x20LDL\x20uptake\x20from\x20the\x20circulation</strong>,\x20<strong>bringing\x20down\x20the\x20LDL-cholesterol</strong>\x20levels\x20in\x20patients\x20with\x20familial\x20hypercholesterolemia.</p>\x0a<p><strong>PCSK9\x20inhibitors</strong>\x20are\x20indicated\x20only\x20as\x20<strong>adjunctive\x20therapy</strong>\x20in\x20patients\x20with\x20<strong>familial\x20hypercholesterolemia</strong>\x20or\x20<strong>established\x20atherosclerotic\x20cardiovascular\x20disease</strong>\x20who\x20have\x20<strong>elevated\x20LDL-cholesterol\x20levels</strong>\x20<strong>despite</strong>\x20being\x20on\x20<strong>maximum</strong>\x20<strong>statin</strong>\x20therapy.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Omalizumab</strong>\x20is\x20a\x20monoclonal\x20antibody\x20against\x20<strong>IgE</strong>.\x20It\x20is\x20approved\x20for\x20use\x20in\x20patients\x20with\x20<strong>asthma</strong>\x20with\x20<strong>elevated\x20levels\x20of\x20circulating\x20IgE</strong>.</p>\x0a<p>Option\x20C:\x20<strong>Bevacizumab</strong>\x20is\x20a\x20monoclonal\x20antibody\x20against\x20<strong>VEGF</strong>.\x20It\x20is\x20approved\x20for\x20use\x20in\x20patients\x20with\x20<strong>metastatic\x20colorectal\x20cancers</strong>\x20and\x20<strong>wet\x20age-related\x20macular\x20degeneration&nbsp;</strong>(intravitreal\x20administration).</p>\x0a<p>Option\x20D:\x20<strong>Natalizumab</strong>\x20is\x20a\x20monoclonal\x20antibody\x20against&nbsp;&alpha;4\x20integrin.\x20It\x20prevents&nbsp;<strong>&alpha;<sub>4</sub>&beta;<sub>1</sub></strong>\x20interaction\x20with\x20VCAM-1,\x20thus\x20restricting\x20T-cell\x20diapedesis\x20into\x20the\x20brain.\x20It\x20is\x20approved\x20for\x20use\x20in\x20<strong>multiple\x20sclerosis</strong>.\x20The\x20use\x20of\x20natalizumab\x20in\x20a\x20patient\x20requires\x20<strong>checking\x20for\x20antibodies\x20against\x20the\x20JC\x20virus</strong>.\x20The\x20<strong>presence\x20of\x20these\x20antibodies</strong>\x20indicates\x20a\x20latent\x20infection,\x20and\x20is\x20a\x20<strong>contraindication\x20to\x20the\x20use\x20of\x20natalizumab</strong>.\x20Natalizumab\x20can\x20cause\x20JC-virus\x20antibody-positive\x20patients\x20to\x20develop\x20multifocal\x20leukoencephalopathy.&nbsp;</p>\x0a<p>Note:\x20<strong>Vedolizumab</strong>\x20is\x20a\x20monoclonal\x20antibody\x20that\x20prevents\x20only\x20<strong>&alpha;<sub>4</sub>&beta;<sub>7</sub></strong>\x20interaction\x20and\x20is\x20approved\x20for\x20use\x20in\x20<strong>Crohn\x27s\x20disease\x20</strong>and<strong>\x20ulcerative\x20colitis.</strong></p>','FHOBT','sgzie','<p>Ethanol\x20consumption\x20inhibits\x20vasopressin\x20secretion\x20from\x20posterior\x20pituitary\x20gland.</p>\x0a<p>Drugs\x20inhibiting\x20or\x20decreasing\x20vasopressin\x20release</p>\x0a<table\x20style=\x22width:\x20318px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20141px;\x22>Stimulating\x20vasopressin\x20release</td>\x0a<td\x20style=\x22width:\x20166px;\x22>Inhibiting\x20vasopressin\x20release</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20141px;\x22>\x0a<p>Vincristine</p>\x0a<p>Cyclophoshamide</p>\x0a<p>Nicotine</p>\x0a<p>Tricyclic\x20antidepressants</p>\x0a<p>Epinephrine</p>\x0a<p>High\x20doses\x20of\x20morphine</p>\x0a</td>\x0a<td\x20style=\x22width:\x20166px;\x22>\x0a<p>Ethanol</p>\x0a<p>Phenytoin</p>\x0a<p>Glucocorticoids</p>\x0a<p>Haloperidol</p>\x0a<p>Fluphenazine</p>\x0a<p>Promethazine</p>\x0a<p>Low\x20doses\x20of\x20morphine</p>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>&nbsp;</p>\x0a<p>&nbsp;</p>\x0a<p>Remember</p>\x0a<p>Lithium:\x20inhibits\x20renal\x20effects\x20of\x20vasopressin\x20but\x20enhances\x20central\x20vasopressin\x20secretion\x20Carbamazepine:\x20produces\x20antidiuresis\x20in\x20central\x20diabetes\x20insipidus\x20through\x20renal\x20action;\x20but\x20inhibits\x20central\x20vasopressin\x20secretion</p>','incorrectAnswers','avgTimeResult','The\x20image\x20below\x20shows\x20the\x20metabolic\x20pathways\x20of\x20levodopa\x20in\x20the\x20periphery\x20and\x20brain.\x20Identify\x20the\x20drug\x20that\x20corresponds\x20to\x20the\x20action\x20of\x20A\x20in\x20the\x20following','eoolA','ncMFI','Preclinical','AkAQq','qJaIg','get','All\x20of\x20the\x20following\x20agents\x20act\x20by\x20intracellular\x20receptors\x20except\x20______','custom_quiz.html','BjvWI','1775716hpbbkD','incomplete','Abciximab','ptPvP','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','video[data-src]','fdSEN','yXSAE','Diltiazem','XfxWv','HPHZj','A\x2065-year-old\x20woman\x20with\x20chronic\x20kidney\x20disease\x20was\x20given\x20a\x20diuretic\x20intravenously.\x20Following\x20administration\x20of\x20the\x20drug,\x20she\x20developed\x20tinnitus\x20and\x20diminished\x20hearing.\x20Which\x20of\x20the\x20following\x20drugs\x20was\x20most\x20likely\x20given?','<p>The\x20phase\x200/\x20microdosing\x20stage\x20is\x20not\x20mandatory\x20and\x20not\x20clearly\x20categorized\x20by\x20regulatory\x20authorities\x20yet.</p>\x0a<p>Phase\x200\x20studies</p>\x0a<ul>\x0a<li>Very\x20low\x20doses\x20of\x20drugs,\x20usually\x201/100th\x20of\x20the\x20estimated\x20human\x20dose\x20or\x20a\x20maximum\x20of\x20100\x20mcg\x20is\x20used.</li>\x0a<li>They\x20are\x20done\x20to\x20obtain\x20pharmacokinetics\x20data\x20in\x20humans\x20at\x20a\x20very\x20early\x20stage\x20of\x20drug\x20development\x20Preclinical,\x20phase\x20I,\x20phase\x20II,\x20and\x20phase\x20III\x20studies\x20are\x20mandatory\x20for\x20drug\x20approval\x20process\x20(options\x20a,\x20c\x20and\x20d).</li>\x0a</ul>','PWddw','Hypertrichosis\x20of\x20eyelashes\x20is\x20seen\x20with\x20the\x20following\x20antiglaucoma\x20agents','NlNSa','tawDY','ITbvq','IgFVT','yZwXH','table','Formoterol','<p><strong>Ethacrynic\x20acid\x20</strong>is\x20the\x20diuretic\x20that\x20was\x20most\x20likely\x20given\x20as\x20it\x20is\x20commonly\x20associated\x20with<strong>\x20ototoxicity</strong>.</p>\x0a<p>Ototoxicity\x20occurs\x20with\x20<strong>rapid\x20intravenous\x20infusion</strong>\x20and\x20the\x20hearing\x20impairment\x20and\x20deafness\x20are\x20usually\x20<strong>reversible.</strong></p>\x0a<p>Ethacrynic\x20acid\x20should\x20be\x20used\x20only\x20in\x20patients\x20who\x20are\x20not\x20able\x20to\x20tolerate\x20other\x20loop\x20diuretics.</p>','bookmarked','Cholinergic\x20in\x20parasympathetic,\x20adrenergic\x20in\x20sympathetic','pMrzs','Levodopa','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','ohmDp','Inhibition\x20of\x20fibrinolysis\x20is\x20caused\x20by','OCPfk','rQKYX','gray','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','bIACp','npAsG','<p>Cangrelor\x20is\x20an\x20adenosine\x20analog\x20that\x20binds\x20reversibly\x20to\x20P2Y12\x20receptors\x20and\x20inhibits\x20it.</p>\x0a<p>GPIIb/IIIa\x20inhibitors:</p>\x0a<ul>\x0a<li>Eptifibatide</li>\x0a<li>Abciximab:\x20highest\x20incidence\x20of\x20thrombocytopenia</li>\x0a<li>Tirofiban</li>\x0a</ul>','PIymu','<p><strong>Cefoxitin</strong>,\x20cefmetazole\x20and\x20cefotetan\x20are\x20the\x20second\x20generation\x20cephalosporins\x20that\x20are\x20<strong>active\x20against\x20anaerobic\x20bacteria</strong>\x20(B\x20fragilis).</p>\x0a<p><strong>Cefazolin</strong>\x20is\x20a\x20first\x20generation\x20parenteral\x20cephalosporin\x20(option\x20a).</p>\x0a<p><strong>Cefixime</strong>\x20has\x20poor\x20activity\x20against\x20Staph\x20aureus\x20(option\x20c).</p>\x0a<p>Cephalosporins\x20having\x20antipseudomonal\x20activity:</p>\x0a<ul>\x0a<li><strong>Cefoperazone</strong>\x20(option\x20b)</li>\x0a<li>Ceftazidime</li>\x0a<li>Cefepime</li>\x0a<li>Cefpirome</li>\x0a</ul>','error','Propranolol','<p><strong>Cimetidine\x20causes\x20maximum\x20hepatic\x20enzyme\x20inhibition\x20among\x20the\x20given\x20options.</strong></p>\x0a<p>Cimetidine\x20inhibits\x20CYP\x20enzymes\x20like\x20CYP1A2,\x20CYP2C9,\x20and\x20CYP2D6.\x20It\x20can\x20interfere\x20with\x20the\x20metabolism\x20of\x20drugs\x20that\x20are\x20substrates\x20of\x20the\x20above\x20enzymes.</p>\x0a<p>Ranitidine\x20also\x20interacts\x20with\x20CYP\x20enzymes\x20but\x20the\x20affinity\x20is\x20only\x2010%\x20to\x20that\x20of\x20cimetidine\x20(Option\x20A).</p>\x0a<p>Famotidine\x20and\x20nizatidine\x20are\x20considered\x20safer\x20with\x20respect\x20to\x20enzyme\x20inhibition\x20(Options\x20C\x20and\x20D).</p>','IIveH','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','__proto__','zhmWx','KYSzY','RQXTB','qKhAI','Clopidogrel','ltBlO','explanation_images','VvGxs','<p>Features\x20of\x20fetal\x20hydantoin\x20syndrome</p>\x0a<ul>\x0a<li>Digital\x20hypoplasia</li>\x0a<li>Microcephaly</li>\x0a<li>Cleft\x20lip,\x20cleft\x20palate\x20and\x20other\x20minor\x20craniofacial\x20abnormalities</li>\x0a</ul>\x0a<p>&nbsp;</p>','WLjOL','nHxDT','bqDeh','wvANe','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','SZWVu','bind','prototype','zjyEn','pOrhk','vngOE','nJpTD','oJXrU','AlJTt','rSRye','pDkew','map','<p>Both\x20tamsulosin\x20and\x20silodosin\x20have\x20higher\x20alpha\x201A\x20selectivity\x20over\x20alpha\x201B\x20receptors.</p>\x0a<p>Tamsulosin\x20is\x20an\x20alpha\x201A/1D\x20selective\x20blocker.</p>\x0a<p>Selective\x20alpha\x201A\x20vs.\x20non-selective\x20alpha\x201\x20blockers:</p>\x0a<p>Advantage:</p>\x0a<ul>\x0a<li>Less\x20interference\x20with\x20blood\x20pressure</li>\x0a<li>Lower\x20incidence\x20of\x20dizziness\x20and\x20orthostatic\x20hypotension</li>\x0a</ul>\x0a<p>Disadvantage:</p>\x0a<ul>\x0a<li>Higher\x20incidence\x20of\x20abnormal\x20ejaculation\x20or\x20retrograde\x20ejaculation</li>\x0a</ul>\x0a<p>Prazosin\x20is\x20a\x20non-selective\x20alpha\x201\x20blocker;\x20it\x20has\x20equal\x20selectivity\x20for\x20alpha\x201A,\x201B\x20and\x201D\x20receptors\x20&nbsp;(option\x20a).</p>','Trimipramine','LBBId','slRnr','Marked','Natalizumab','M4\x20receptors','Rhynz','Synaptic\x20transmission\x20in\x20sympathetic\x20and\x20parasympathetic\x20ganglia\x20is\x20predominantly','Noncompetitive\x20inhibition','Angiotensin\x20converting\x20enzyme\x20inhibitor','RgxCT','timeDisplay','forEach','isArray','mxmMB','dKRRI','RBwch','gjAhH','nav-btn-marked-review','DzQXs','yhHZK','nav-btn-bookmarked','Ethacrynic\x20acid','YIXwf','umLSP','Romiplostim','study','<p><strong>Loop\x20diuretics</strong>\x20decreases\x20calcium\x20reabsorption\x20and\x20can\x20result\x20in\x20<strong>hypocalcemia</strong></p>\x0a<p>Loop\x20diuretics\x20by\x20inhibiting\x20the\x20Na+/K+/2Cl-\x20transporter\x20decreases\x20calcium\x20and\x20magnesium\x20reabsorption\x20by\x20abolishing\x20the\x20transepithelial\x20potential\x20difference\x20that\x20is\x20the\x20dominant\x20force\x20for\x20these\x20cations\x20reabsorption.</p>\x0a<p><strong>Thiazide\x20diuretics</strong>\x20decrease\x20excretion\x20of\x20calcium\x20and\x20can\x20result\x20in\x20<strong>hypercalcemia</strong>\x20(option\x20a).</p>\x0a<p>Carbonic\x20anhydrase\x20inhibitors\x20does\x20not\x20alter\x20calcium\x20levels\x20(option\x20c).</p>\x0a<p>Acute\x20effects\x20of\x20different\x20diuretics\x20on\x20excretion\x20of\x20different\x20electrolytes:</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Diuretics</td>\x0a<td>Sodium</td>\x0a<td>Potassium</td>\x0a</tr>\x0a<tr>\x0a<td>Carbonic\x20anhydrase\x20inhibitors</td>\x0a<td>&uarr;</td>\x0a<td>&uarr;&uarr;</td>\x0a</tr>\x0a<tr>\x0a<td>Osmotic\x20diuretics</td>\x0a<td>&uarr;&uarr;</td>\x0a<td>&uarr;</td>\x0a</tr>\x0a<tr>\x0a<td>Loop\x20diuretics</td>\x0a<td>&uarr;&uarr;&uarr;</td>\x0a<td>&uarr;</td>\x0a</tr>\x0a<tr>\x0a<td>Thiazides</td>\x0a<td>&uarr;&uarr;</td>\x0a<td>&uarr;</td>\x0a</tr>\x0a<tr>\x0a<td>Epithelial\x20sodium\x20channel\x20blockers</td>\x0a<td>&uarr;</td>\x0a<td>&darr;</td>\x0a</tr>\x0a<tr>\x0a<td>Aldosterone\x20antagonists</td>\x0a<td>&uarr;</td>\x0a<td>&darr;</td>\x0a</tr>\x0a</tbody>\x0a</table>','ILzCJ','Pirbuterol','pathname','Ibuprofen','Metoprolol','Omalizumab','Steroid','Both\x20b\x20and\x20c','onclick','CLWvH','Thyroid\x20hormones','Glulisine','<ul>\x0a<li>Edrophonium\x20attaches\x20reversibly\x20to\x20choline\x20subsite\x20of\x20the\x20active\x20esteric\x20site.</li>\x0a<li>It\x20does\x20not\x20form\x20any\x20covalent\x20bond\x20with\x20the\x20enzyme\x20and\x20it\x20has\x20a\x20rapid\x20renal\x20elimination\x20due\x20to\x20its\x20quaternary\x20structure\x20making\x20it\x20a\x20very\x20short\x20acting\x20drug\x20(5-20\x20min).</li>\x0a<li>Edrophonium\x20is\x20used\x20in\x20the\x20diagnosis\x20of\x20myasthenia\x20gravis\x20because\x20of\x20the\x20short\x20duration\x20of\x20action\x20Neostigmine,\x20physostigmine\x20and\x20pyridostigmine\x20have\x20longer\x20duration\x20of\x20action\x20(options\x20a,b\x20and\x20c).</li>\x0a<li>They\x20bind\x20to\x20both\x20esteric\x20and\x20anionic\x20site\x20of\x20the\x20AChE\x20enzyme\x20and\x20carbamylate\x20the\x20enzyme.</li>\x0a<li>Carbamylated\x20enzyme\x20is\x20hydrolysed\x20slowly\x20resulting\x20in\x20reversible\x20but\x20longer\x20acting\x20inhibition\x20of\x20AChE.</li>\x0a</ul>','No\x20question\x20text\x20available','JXYzg','oqrSh','data-option-index','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','TILMQ','YtaZJ','UhAnn','kmkMk','Cefoxitin\x20has\x20no\x20activity\x20against\x20anaerobes','XjXYM','zJmyC','Induction\x20of\x20CYP2E1','AIJSZ','JBsYh','ZhOSt','none','uRVBT','xMBnf','YVGlm','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','getItem','timeSpent','Which\x20of\x20the\x20following\x20is\x20cholesterol\x20absorption\x20inhibitor?','Progress\x20loaded.','35778flYCWP','Thiazide','Rupatadine','yUIZs','Apixaban','XhOyz','\x22\x20data-option-index=\x22','Marrow','\x20-\x20Brain\x20And\x20Scalpel','srVxx','Benserazide','-600\x20text-white\x22>','VhtSk','.m3u8','explanationVideoPlayer','wKrVS','VjAZG','VMTSP','cabhC','border-gray-600','text','Carbonic\x20anhydrase\x20inhibitors','<p>Lisinopril\x20is\x20the\x20lysine\x20derivative\x20of\x20enalaprilat\x20(active\x20form\x20of\x20enalapril).</p>\x0a<p>All\x20ACE\x20inhibitors\x20are\x20prodrugs\x20except\x20lisinopril\x20and\x20captopril\x20(option\x20a).</p>\x0a<p>Examples\x20of\x20prodrugs:</p>\x0a<ul>\x0a<li>Prednisone</li>\x0a<li>Levodopa</li>\x0a<li>ACE\x20inhibitors\x20(except\x20lisinopril\x20and\x20captopril)</li>\x0a<li>Sulfasalazine</li>\x0a<li>Methyldopa</li>\x0a<li>Cyclophosphamide</li>\x0a<li>Clopidogrel</li>\x0a</ul>','Naproxen','selected','KWcYp','hXaNC','qHBSO','canPlayType','KxVfk','PlPUG','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','rLIrD','Silodosin','nav-btn-correct','Maximum\x20hepatic\x20enzyme\x20inhibition\x20is\x20seen\x20with\x20______'];_0x517b=function(){return _0x24e08d;};return _0x517b();}function _0x523b(_0x56faf9,_0x21539b){const _0x46a0b0=_0x517b();return _0x523b=function(_0x2cbd63,_0x2b1072){_0x2cbd63=_0x2cbd63-0x165;let _0x32ef4b=_0x46a0b0[_0x2cbd63];return _0x32ef4b;},_0x523b(_0x56faf9,_0x21539b);}function updateQuestionNav(){const _0x2c2835=_0x5da439,_0xc36572={'YjtMl':function(_0x259389){return _0x259389();},'yXSAE':'markReviewBtn','BvztB':_0x2c2835(0x3ed),'vidSq':_0x2c2835(0x21b),'nWjAn':_0x2c2835(0x3b1),'RQXTB':_0x2c2835(0x245),'daiRl':_0x2c2835(0x38a),'ffeHW':function(_0x184a58,_0x336529){return _0x184a58<_0x336529;},'fRmew':function(_0x57b4c7,_0x2a5a8c){return _0x57b4c7!==_0x2a5a8c;},'UpRAB':'NTFoS','SEMjS':function(_0x147406,_0x552a9c){return _0x147406===_0x552a9c;},'IgFVT':_0x2c2835(0x257),'nLTuY':'bLKrG','VSvFu':'xxctp','npAsG':_0x2c2835(0x254),'wmRXW':_0x2c2835(0x25c),'SDKoN':_0x2c2835(0x473),'tkwzm':_0x2c2835(0x1b8),'IBAsQ':_0x2c2835(0x2a6),'EbSHk':_0x2c2835(0x3f1),'PlPUG':_0x2c2835(0x3b7),'jbvwk':_0x2c2835(0x352),'DvyGe':'szGGL','cKwjM':_0x2c2835(0x2c0),'NSCuR':_0x2c2835(0x1c8)};for(let _0x1d74d7=0x0;_0xc36572[_0x2c2835(0x3e5)](_0x1d74d7,questionsData[_0x2c2835(0x39a)]);_0x1d74d7++){if(_0xc36572[_0x2c2835(0x42c)](_0x2c2835(0x442),_0xc36572[_0x2c2835(0x415)]))_0x4e7f3f=_0x16a6a1;else{const _0x554203=document[_0x2c2835(0x431)](_0x2c2835(0x2b9)+_0x1d74d7),_0x167035=questionStates[_0x1d74d7];let _0x1c0df0='';if(_0xc36572[_0x2c2835(0x1cb)](_0x1d74d7,currentQuestionIndex))_0x1c0df0='nav-btn-current';else{if(_0x167035[_0x2c2835(0x211)])_0x1c0df0=_0xc36572[_0x2c2835(0x20c)];else{if(_0x167035[_0x2c2835(0x423)])_0xc36572[_0x2c2835(0x386)]!==_0xc36572['VSvFu']?_0x1c0df0=_0xc36572[_0x2c2835(0x21d)]:_0xc36572['YjtMl'](_0x6a8818);else{if(_0xc36572[_0x2c2835(0x1cb)](currentMode,_0xc36572['wmRXW'])||currentMode===_0xc36572[_0x2c2835(0x40b)]){if(_0xc36572[_0x2c2835(0x1cb)](_0x167035[_0x2c2835(0x425)],_0xc36572[_0x2c2835(0x194)]))_0x1c0df0=_0xc36572[_0x2c2835(0x2ec)];else{if(_0xc36572[_0x2c2835(0x1cb)](_0x167035[_0x2c2835(0x425)],_0xc36572[_0x2c2835(0x3f2)]))_0x1c0df0=_0xc36572[_0x2c2835(0x2a2)];else _0x1c0df0=_0x2c2835(0x1c8);}}else{if(_0xc36572['fRmew'](_0xc36572['jbvwk'],_0xc36572[_0x2c2835(0x2fc)])){if(_0xc36572[_0x2c2835(0x42c)](_0x167035[_0x2c2835(0x414)],null))_0x1c0df0=_0xc36572[_0x2c2835(0x465)];else _0x1c0df0=_0xc36572[_0x2c2835(0x3da)];}else{const _0x189187=_0x34574f[_0x2c2835(0x431)](_0xc36572[_0x2c2835(0x201)]),_0x340b71=_0x142abe[_0x2c2835(0x431)](_0xc36572[_0x2c2835(0x1ca)]),_0x694661=_0x486f82[_0x511846][_0x2c2835(0x423)];_0x189187[_0x2c2835(0x2ea)]=_0x694661?_0xc36572['vidSq']:_0xc36572[_0x2c2835(0x3d8)],_0x340b71['textContent']=_0x694661?_0xc36572[_0x2c2835(0x229)]:_0xc36572[_0x2c2835(0x343)];}}}}}_0x554203[_0x2c2835(0x2ea)]=_0x2c2835(0x3b9)+_0x1c0df0;}}}function jumpToQuestion(_0x52e59e){const _0x49516a=_0x5da439,_0x26a71a={'AeKbC':function(_0x2f973d,_0x55176e){return _0x2f973d(_0x55176e);},'msrLZ':'You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','SKflv':function(_0x360c59){return _0x360c59();},'YNjkP':function(_0x513891,_0x1bb101){return _0x513891>=_0x1bb101;},'aOdkU':function(_0x387a98,_0x3f7741){return _0x387a98<_0x3f7741;},'aTyLu':function(_0x5cb20c,_0x530ddb){return _0x5cb20c===_0x530ddb;},'aUEoU':_0x49516a(0x39d),'kbaHo':function(_0x7fa6af,_0x1fd929){return _0x7fa6af-_0x1fd929;}};_0x26a71a[_0x49516a(0x3a8)](_0x52e59e,0x0)&&_0x26a71a[_0x49516a(0x407)](_0x52e59e,questionsData[_0x49516a(0x39a)])&&(_0x26a71a['aTyLu'](_0x26a71a[_0x49516a(0x2cc)],_0x49516a(0x39d))?(questionStartTime&&(questionStates[currentQuestionIndex][_0x49516a(0x281)]+=_0x26a71a['kbaHo'](Date[_0x49516a(0x382)](),questionStartTime)),currentQuestionIndex=_0x52e59e,displayQuestion(),_0x26a71a['SKflv'](saveProgress)):_0x26a71a[_0x49516a(0x2bc)](_0x3ecc6d,_0x26a71a['msrLZ'])&&_0x26a71a[_0x49516a(0x331)](_0x4b3122));}function updateStats(){const _0x4a67ca=_0x5da439,_0x971a60={'tzRbe':function(_0x4d2bc5,_0x19b0d7){return _0x4d2bc5===_0x19b0d7;},'anTUo':_0x4a67ca(0x25c),'AlJTt':'incorrectCount','BOxLe':_0x4a67ca(0x385),'oJXrU':function(_0x7b30b7,_0x516cea){return _0x7b30b7>_0x516cea;},'xfeIs':function(_0x26830a,_0x488eb1){return _0x26830a*_0x488eb1;},'nrFMv':function(_0x292c03,_0x627d1a){return _0x292c03/_0x627d1a;},'BjvWI':'accuracy','ITbvq':function(_0x2bdbee,_0x3feb80){return _0x2bdbee+_0x3feb80;},'ZhOSt':function(_0x2a24d6,_0x2a8968){return _0x2a24d6%_0x2a8968;}};if(_0x971a60[_0x4a67ca(0x1e7)](currentMode,_0x971a60[_0x4a67ca(0x3fb)])||_0x971a60[_0x4a67ca(0x1e7)](currentMode,_0x4a67ca(0x473))){document[_0x4a67ca(0x431)](_0x4a67ca(0x1bf))[_0x4a67ca(0x373)]=stats[_0x4a67ca(0x421)],document['getElementById'](_0x971a60[_0x4a67ca(0x23d)])[_0x4a67ca(0x373)]=stats[_0x4a67ca(0x1ee)],document[_0x4a67ca(0x431)](_0x971a60[_0x4a67ca(0x1b4)])['textContent']=stats[_0x4a67ca(0x385)];const _0x1339e0=_0x971a60[_0x4a67ca(0x23c)](stats[_0x4a67ca(0x385)],0x0)?Math['round'](_0x971a60[_0x4a67ca(0x17e)](_0x971a60[_0x4a67ca(0x476)](stats[_0x4a67ca(0x421)],stats[_0x4a67ca(0x385)]),0x64)):0x0;document[_0x4a67ca(0x431)](_0x971a60[_0x4a67ca(0x1f9)])['textContent']=_0x971a60[_0x4a67ca(0x20b)](_0x1339e0,'%'),stats[_0x4a67ca(0x2d4)]=questionStates[_0x4a67ca(0x3ab)]((_0x2e554e,_0x523608)=>_0x2e554e+_0x523608[_0x4a67ca(0x281)],0x0);const _0x579899=Math['floor'](stats[_0x4a67ca(0x2d4)]/0x3e8),_0x4b596c=Math['floor'](_0x971a60[_0x4a67ca(0x476)](_0x579899,0x3c)),_0xaac1ff=_0x971a60[_0x4a67ca(0x27a)](_0x579899,0x3c);document['getElementById']('timeSpent')[_0x4a67ca(0x373)]=_0x971a60[_0x4a67ca(0x20b)](_0x4b596c+':',_0xaac1ff['toString']()[_0x4a67ca(0x3b4)](0x2,'0'));}}function setupVideo(_0x2c6e99,_0x31cf5d){const _0x3cd315=_0x5da439,_0x4b9346={'IIveH':_0x3cd315(0x441),'yBLby':_0x3cd315(0x355),'YVoJV':function(_0x2a1396,_0x42cb0b){return _0x2a1396!==_0x42cb0b;},'qHBSO':_0x3cd315(0x390)};if(Hls[_0x3cd315(0x458)]()){const _0x4fe138=new Hls();_0x4fe138[_0x3cd315(0x30f)](_0x31cf5d),_0x4fe138[_0x3cd315(0x3d3)](_0x2c6e99);}else{if(_0x2c6e99[_0x3cd315(0x2a0)](_0x4b9346[_0x3cd315(0x46d)])){if(_0x4b9346['YVoJV'](_0x3cd315(0x276),_0x4b9346[_0x3cd315(0x29f)]))_0x2c6e99['src']=_0x31cf5d;else{_0x2e0504['getElementById'](_0x3cd315(0x18a))[_0x3cd315(0x3cf)]=_0x4b9346[_0x3cd315(0x224)];return;}}}}function displayQuestion(){const _0x2aacd5=_0x5da439,_0x3fdaab={'EcTOJ':function(_0x5a7575,_0x2faab0){return _0x5a7575+_0x2faab0;},'pkVzz':'div','wSWDK':_0x2aacd5(0x29c),'hXaNC':function(_0x1bc830,_0x3e648b){return _0x1bc830+_0x3e648b;},'qMxjE':_0x2aacd5(0x367),'gGZMY':function(_0x1085cc,_0x44c05a){return _0x1085cc+_0x44c05a;},'ptPvP':function(_0x58f70a){return _0x58f70a();},'kqcHf':_0x2aacd5(0x3fa),'oqrSh':'none','RFFjd':function(_0x1c71ed){return _0x1c71ed();},'xZDUx':_0x2aacd5(0x1a1),'wOayy':function(_0x4f0ac1,_0x5020ea){return _0x4f0ac1!==_0x5020ea;},'gjAhH':_0x2aacd5(0x273),'sgzie':function(_0x2a3d9d,_0x5af7a8){return _0x2a3d9d(_0x5af7a8);},'QgxSq':_0x2aacd5(0x26e),'eDgiq':function(_0x340bc1,_0x5ac9b4){return _0x340bc1===_0x5ac9b4;},'ExXDX':_0x2aacd5(0x18a),'ANpkU':_0x2aacd5(0x441),'vngOE':function(_0x131536,_0x55d111){return _0x131536*_0x55d111;},'Bpliy':function(_0x4b8bbd,_0xef8784){return _0x4b8bbd/_0xef8784;},'TYfuC':_0x2aacd5(0x44b),'czliZ':_0x2aacd5(0x3f5),'YcVez':function(_0x3d48ad){return _0x3d48ad();},'SpFMx':_0x2aacd5(0x3d7),'TBDnD':_0x2aacd5(0x409),'CYecS':_0x2aacd5(0x2a9),'bwRGk':_0x2aacd5(0x2ed),'gziop':_0x2aacd5(0x2dc),'sPnsX':_0x2aacd5(0x3c8),'ZLwFF':function(_0x2fca11){return _0x2fca11();},'uucSl':_0x2aacd5(0x473),'lswEC':_0x2aacd5(0x306),'aIJHw':function(_0xdb26b9){return _0xdb26b9();}};if(!questionsData||_0x3fdaab[_0x2aacd5(0x2de)](questionsData['length'],0x0)){document[_0x2aacd5(0x431)](_0x3fdaab['ExXDX'])['innerHTML']=_0x3fdaab[_0x2aacd5(0x1e4)];return;};const _0x5178bf=questionsData[currentQuestionIndex];questionStartTime=Date['now'](),selectedOption=questionStates[currentQuestionIndex][_0x2aacd5(0x414)];const _0x264987=_0x3fdaab[_0x2aacd5(0x23a)](_0x3fdaab[_0x2aacd5(0x42e)](currentQuestionIndex+0x1,questionsData['length']),0x64);document[_0x2aacd5(0x431)](_0x3fdaab['TYfuC'])[_0x2aacd5(0x2be)][_0x2aacd5(0x42b)]=_0x264987+'%',document[_0x2aacd5(0x431)](_0x3fdaab[_0x2aacd5(0x45b)])['textContent']=_0x3fdaab[_0x2aacd5(0x39b)](currentQuestionIndex,0x1),_0x3fdaab['YcVez'](updateQuestionNav),document['getElementById'](_0x3fdaab['SpFMx'])[_0x2aacd5(0x308)]=currentQuestionIndex===0x0,document['getElementById'](_0x3fdaab[_0x2aacd5(0x3cc)])[_0x2aacd5(0x1e8)][_0x2aacd5(0x172)](_0x2aacd5(0x403)),document[_0x2aacd5(0x431)](_0x3fdaab[_0x2aacd5(0x19e)])[_0x2aacd5(0x3cf)]=_0x5178bf[_0x2aacd5(0x298)]||_0x2aacd5(0x26b);let _0x1b9953='';if(_0x5178bf[_0x2aacd5(0x467)])_0x1b9953+=_0x2aacd5(0x35f)+_0x5178bf['question_audio']+_0x2aacd5(0x1fe);if(_0x5178bf['question_video'])_0x1b9953+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0x5178bf['question_video']+_0x2aacd5(0x1db);_0x5178bf[_0x2aacd5(0x16c)]&&_0x5178bf[_0x2aacd5(0x16c)][_0x2aacd5(0x24e)](_0x3719a5=>{const _0xaed9be=_0x2aacd5;if(_0x3719a5)_0x1b9953+=_0xaed9be(0x215)+_0x3719a5+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';});document[_0x2aacd5(0x431)](_0x3fdaab['CYecS'])[_0x2aacd5(0x3cf)]=_0x1b9953;const _0x497e46=document[_0x2aacd5(0x431)](_0x3fdaab['bwRGk']);_0x497e46['innerHTML']='',_0x497e46[_0x2aacd5(0x1e8)][_0x2aacd5(0x3be)](_0x3fdaab[_0x2aacd5(0x2ee)]),_0x5178bf[_0x2aacd5(0x37f)]&&Array[_0x2aacd5(0x24f)](_0x5178bf[_0x2aacd5(0x37f)])&&(_0x5178bf[_0x2aacd5(0x37f)][_0x2aacd5(0x24e)]((_0x4b77df,_0x18cf59)=>{const _0x1f9588=_0x2aacd5,_0x15f5b3=String[_0x1f9588(0x176)](_0x3fdaab[_0x1f9588(0x43e)](0x41,_0x18cf59)),_0x533b48=selectedOption===_0x18cf59,_0x5e0093=document[_0x1f9588(0x459)](_0x3fdaab[_0x1f9588(0x3c1)]);_0x5e0093[_0x1f9588(0x3cf)]=_0x1f9588(0x400)+(_0x533b48?_0x3fdaab[_0x1f9588(0x453)]:'')+_0x1f9588(0x28a)+_0x18cf59+_0x1f9588(0x234)+_0x15f5b3+_0x1f9588(0x35a)+(_0x4b77df['text']||_0x3fdaab[_0x1f9588(0x29e)](_0x3fdaab[_0x1f9588(0x341)],_0x3fdaab[_0x1f9588(0x39b)](_0x18cf59,0x1)))+_0x1f9588(0x379),_0x497e46[_0x1f9588(0x337)](_0x5e0093);}),_0x497e46[_0x2aacd5(0x323)](_0x3fdaab[_0x2aacd5(0x411)],function(_0x4ab3f8){const _0x3abf92=_0x2aacd5,_0x2418d0={'MXvTw':function(_0x5092e8){const _0x5802ee=_0x523b;return _0x3fdaab[_0x5802ee(0x1fd)](_0x5092e8);},'hYbpc':_0x3fdaab['kqcHf'],'phlbV':_0x3fdaab[_0x3abf92(0x26d)],'wMaIY':function(_0x3d737b){const _0x98ef8=_0x3abf92;return _0x3fdaab[_0x98ef8(0x1fd)](_0x3d737b);},'cDTzv':function(_0x5a9d51){const _0x284a1d=_0x3abf92;return _0x3fdaab[_0x284a1d(0x1cc)](_0x5a9d51);},'kINjM':_0x3fdaab[_0x3abf92(0x1dd)]};if(_0x3fdaab['wOayy'](_0x3fdaab['gjAhH'],_0x3fdaab[_0x3abf92(0x253)]))_0x2418d0[_0x3abf92(0x2f6)](_0x3c215b)?(_0x4aa9d0[_0x3abf92(0x431)](_0x2418d0[_0x3abf92(0x1c3)])[_0x3abf92(0x2be)][_0x3abf92(0x38f)]=_0x2418d0[_0x3abf92(0x2b5)],_0x2418d0[_0x3abf92(0x2df)](_0x234148)):(_0x2418d0['cDTzv'](_0x587e56),_0x377fc4[_0x3abf92(0x431)](_0x3abf92(0x3fa))[_0x3abf92(0x2be)][_0x3abf92(0x38f)]=_0x2418d0[_0x3abf92(0x190)]);else{const _0x4709e5=_0x4ab3f8[_0x3abf92(0x2c2)][_0x3abf92(0x3aa)](_0x3abf92(0x180));if(_0x4709e5){const _0x3f0d96=_0x3fdaab['sgzie'](parseInt,_0x4709e5[_0x3abf92(0x195)](_0x3fdaab[_0x3abf92(0x3ca)]));_0x3fdaab[_0x3abf92(0x1ec)](selectOption,_0x3f0d96);}}})),_0x3fdaab['YcVez'](updateBookmarkButton),_0x3fdaab['ZLwFF'](updateMarkReviewButton),(currentMode===_0x3fdaab[_0x2aacd5(0x358)]||currentMode===_0x3fdaab[_0x2aacd5(0x1b0)])&&!isQuizCompleted&&_0x3fdaab[_0x2aacd5(0x46f)](startTimer);}function selectOption(_0x18db89){const _0x35801a=_0x5da439,_0x19936d={'WKnpq':'none','rSRye':function(_0x58a02c){return _0x58a02c();},'TaJyH':function(_0x2f0bbf,_0x40e212){return _0x2f0bbf!==_0x40e212;},'APcPO':_0x35801a(0x29c),'etBnE':'optionsContainer','ujYWS':_0x35801a(0x2dc),'jxNcs':function(_0x4e4fb9,_0x24200c){return _0x4e4fb9-_0x24200c;},'fOwMm':function(_0x3fcc4e,_0x33f11f){return _0x3fcc4e===_0x33f11f;},'TVXAh':function(_0x47f096){return _0x47f096();}},_0x5a45e6=document[_0x35801a(0x431)](_0x19936d[_0x35801a(0x401)]);if(_0x5a45e6[_0x35801a(0x1e8)][_0x35801a(0x2b7)](_0x19936d[_0x35801a(0x301)]))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x35801a(0x281)]+=_0x19936d['jxNcs'](Date[_0x35801a(0x382)](),questionStartTime),questionStartTime=Date[_0x35801a(0x382)]()),selectedOption=_0x18db89,questionStates[currentQuestionIndex][_0x35801a(0x414)]=_0x18db89,document[_0x35801a(0x1a3)](_0x35801a(0x180))[_0x35801a(0x24e)]((_0x1395ce,_0x3c523b)=>{const _0x584931=_0x35801a;_0x19936d[_0x584931(0x42d)](_0x584931(0x255),_0x584931(0x1a0))?_0x1395ce[_0x584931(0x1e8)][_0x584931(0x175)](_0x19936d['APcPO'],_0x3c523b===_0x18db89):(_0x50f879[_0x584931(0x431)]('modeModal')[_0x584931(0x2be)][_0x584931(0x38f)]=_0x19936d['WKnpq'],_0x19936d[_0x584931(0x23e)](_0x4b2188));}),_0x19936d['fOwMm'](currentMode,_0x35801a(0x25c))||_0x19936d['fOwMm'](currentMode,_0x35801a(0x473))?_0x19936d[_0x35801a(0x23e)](processAnswer):(_0x19936d[_0x35801a(0x2ff)](questionStates[currentQuestionIndex][_0x35801a(0x425)],_0x35801a(0x43b))&&(questionStates[currentQuestionIndex][_0x35801a(0x425)]=_0x19936d[_0x35801a(0x301)],stats[_0x35801a(0x385)]++,stats[_0x35801a(0x455)]--),_0x19936d[_0x35801a(0x320)](updateQuestionNav)),saveProgress();}function processAnswer(){const _0x267dbe=_0x5da439,_0x1574ea={'QvmGd':'userHistory','QwMfF':function(_0x50303a,_0x1c269b){return _0x50303a===_0x1c269b;},'xJKNk':function(_0x16b37a,_0x256336){return _0x16b37a===_0x256336;},'RaqCf':_0x267dbe(0x43b),'YxPqo':function(_0x504c4e,_0x4ffc3e){return _0x504c4e===_0x4ffc3e;},'jSflm':_0x267dbe(0x468),'TOeod':_0x267dbe(0x1b8),'WNTTB':_0x267dbe(0x3f1),'yGNnu':function(_0x291dd6){return _0x291dd6();},'dKnyw':function(_0x2e3fa0,_0x32f74f){return _0x2e3fa0(_0x32f74f);},'bhIlK':function(_0x4cfdb4){return _0x4cfdb4();}},_0x21b26d=questionsData[currentQuestionIndex],_0x5ed956=_0x21b26d[_0x267dbe(0x450)];if(selectedOption===null)return;const _0x538712=_0x21b26d['choices'][selectedOption],_0xe98aa8=_0x1574ea['QwMfF'](_0x538712['id'],_0x5ed956);if(_0x1574ea[_0x267dbe(0x310)](questionStates[currentQuestionIndex][_0x267dbe(0x425)],_0x1574ea[_0x267dbe(0x1d2)])){if(_0x1574ea[_0x267dbe(0x313)](_0x1574ea[_0x267dbe(0x1d8)],_0x267dbe(0x468))){stats[_0x267dbe(0x385)]++,stats[_0x267dbe(0x455)]--;if(_0xe98aa8)stats['correctAnswers']++;else stats[_0x267dbe(0x1ee)]++;}else{const _0x3e701d=_0xe9a9e5[_0x267dbe(0x3fe)](_0x448e07[_0x267dbe(0x280)](_0x1574ea[_0x267dbe(0x384)]))||{};_0x3e701d[_0xeeaecc]&&(delete _0x3e701d[_0x47932f],_0x59d9bd[_0x267dbe(0x437)](_0x1574ea[_0x267dbe(0x384)],_0x4bf4f9['stringify'](_0x3e701d)),_0x1a483e[_0x267dbe(0x424)](_0x267dbe(0x2e6)));}}questionStates[currentQuestionIndex][_0x267dbe(0x425)]=_0xe98aa8?_0x1574ea[_0x267dbe(0x1e3)]:_0x1574ea[_0x267dbe(0x3cd)],_0x1574ea[_0x267dbe(0x33c)](updateStats),_0x1574ea[_0x267dbe(0x43c)](showInlineFeedback,_0xe98aa8),_0x1574ea[_0x267dbe(0x31e)](updateQuestionNav);}function showInlineFeedback(_0x530138){const _0x20599b=_0x5da439,_0x2dc812={'ZOVwI':'Incorrect','sYDWE':function(_0x1078a7,_0xe1c255){return _0x1078a7===_0xe1c255;},'NEjgn':'RThHR','lEhiQ':_0x20599b(0x1b8),'qHcBK':function(_0x44291b,_0x1d2611){return _0x44291b===_0x1d2611;},'Befqg':_0x20599b(0x3f1),'prxVI':function(_0x4d917e,_0x1d4184){return _0x4d917e!==_0x1d4184;},'xqPjH':_0x20599b(0x25c),'pRYRI':function(_0x2dfbe7,_0xc98c83){return _0x2dfbe7!==_0xc98c83;},'soUVF':_0x20599b(0x2ed),'hpnPO':_0x20599b(0x2dc),'VMTSP':function(_0x41d169){return _0x41d169();}};if(_0x2dc812['prxVI'](currentMode,_0x2dc812[_0x20599b(0x371)])&&_0x2dc812['pRYRI'](currentMode,_0x20599b(0x473)))return;const _0x30dbcc=document[_0x20599b(0x431)](_0x2dc812[_0x20599b(0x1a9)]),_0x315ccc=_0x30dbcc[_0x20599b(0x1a3)](_0x20599b(0x180)),_0x12c7b4=questionsData[currentQuestionIndex],_0xc87772=_0x12c7b4['correct_choice_id'];let _0x39d70a=_0x12c7b4[_0x20599b(0x37f)][_0x20599b(0x3e2)](_0x495a3a=>_0x495a3a['id']===_0xc87772);_0x30dbcc[_0x20599b(0x1e8)][_0x20599b(0x172)](_0x2dc812[_0x20599b(0x368)]),_0x315ccc[_0x20599b(0x24e)]((_0x40c6ec,_0x1c308d)=>{const _0x546a6c=_0x20599b,_0x41b764={'cabhC':_0x546a6c(0x3f1),'QHBNM':_0x2dc812['ZOVwI']};if(_0x2dc812['sYDWE'](_0x2dc812[_0x546a6c(0x1a7)],_0x2dc812['NEjgn'])){_0x40c6ec[_0x546a6c(0x1e8)]['remove'](_0x546a6c(0x29c));if(_0x2dc812[_0x546a6c(0x2db)](_0x1c308d,_0x39d70a))_0x40c6ec['classList'][_0x546a6c(0x172)](_0x2dc812[_0x546a6c(0x32e)]);else{if(_0x2dc812[_0x546a6c(0x3bb)](_0x1c308d,selectedOption)&&!_0x530138)_0x40c6ec[_0x546a6c(0x1e8)][_0x546a6c(0x172)](_0x2dc812['Befqg']);}}else _0x5ce2fa=_0x41b764[_0x546a6c(0x296)],_0x54bbc8=_0x41b764[_0x546a6c(0x342)];}),_0x2dc812[_0x20599b(0x295)](showSolution);}function showSolution(){const _0x25211a=_0x5da439,_0x314cd9={'fQroh':'timerContainer','kFLqH':function(_0x4cbd3b,_0x40e1ac){return _0x4cbd3b(_0x40e1ac);},'KoxzI':function(_0x3511d3,_0x2c8712){return _0x3511d3!==_0x2c8712;},'Pgelg':_0x25211a(0x25c),'TwIcZ':function(_0x85bd76,_0x47449e){return _0x85bd76!==_0x47449e;},'YtaZJ':_0x25211a(0x473),'QxBCb':_0x25211a(0x419),'tJsMh':_0x25211a(0x39f),'Kktzc':_0x25211a(0x292),'UXwRU':_0x25211a(0x403),'LJQdf':'.m3u8','YIXwf':_0x25211a(0x27e),'brxTc':_0x25211a(0x454),'ncoWM':_0x25211a(0x334),'RAWwT':_0x25211a(0x409)};if(_0x314cd9[_0x25211a(0x18c)](currentMode,_0x314cd9['Pgelg'])&&_0x314cd9[_0x25211a(0x319)](currentMode,_0x314cd9[_0x25211a(0x271)]))return;const _0x5cd28e=questionsData[currentQuestionIndex];document[_0x25211a(0x431)](_0x314cd9[_0x25211a(0x32f)])[_0x25211a(0x3cf)]=_0x5cd28e[_0x25211a(0x2d8)]||'No\x20solution\x20provided';const _0xf222d1=document[_0x25211a(0x431)](_0x314cd9['tJsMh']),_0x34605c=document[_0x25211a(0x431)](_0x314cd9[_0x25211a(0x1df)]),_0x387526=_0x5cd28e[_0x25211a(0x2e3)];if(_0x387526){_0xf222d1['classList']['remove'](_0x314cd9[_0x25211a(0x433)]);if(_0x387526[_0x25211a(0x41f)](_0x314cd9[_0x25211a(0x363)]))setupVideo(_0x34605c,_0x387526);else _0x34605c['src']=_0x387526;}else _0x314cd9['KoxzI'](_0x314cd9[_0x25211a(0x259)],_0x314cd9[_0x25211a(0x259)])?_0x7b82a['getElementById'](_0x314cd9['fQroh'])['classList'][_0x25211a(0x3be)](_0x25211a(0x403)):_0xf222d1[_0x25211a(0x1e8)][_0x25211a(0x172)]('hidden');const _0x31e1fd=document[_0x25211a(0x431)](_0x314cd9[_0x25211a(0x44e)]);_0x31e1fd[_0x25211a(0x3cf)]='';_0x5cd28e[_0x25211a(0x357)]&&(_0x31e1fd['innerHTML']+=_0x25211a(0x1c2)+_0x5cd28e[_0x25211a(0x357)]+_0x25211a(0x1fe));_0x5cd28e[_0x25211a(0x2d5)]&&(_0x31e1fd[_0x25211a(0x3cf)]+=_0x25211a(0x33d)+_0x5cd28e['explanation_audio_hin']+_0x25211a(0x1fe));const _0x3eeac4=document[_0x25211a(0x431)](_0x25211a(0x46c));_0x3eeac4[_0x25211a(0x3cf)]='';if(_0x5cd28e[_0x25211a(0x22d)]){if(_0x314cd9[_0x25211a(0x319)](_0x25211a(0x334),_0x314cd9[_0x25211a(0x438)])){const _0x367a29=_0x314cd9[_0x25211a(0x3e0)](_0x1e0bae,_0x4ab5e3[_0x25211a(0x195)](_0x25211a(0x26e)));_0x3aa912(_0x367a29);}else _0x5cd28e['explanation_images'][_0x25211a(0x24e)](_0xa50a86=>{const _0x57ee13=_0x25211a;if(_0xa50a86)_0x3eeac4[_0x57ee13(0x3cf)]+=_0x57ee13(0x16b)+_0xa50a86+_0x57ee13(0x225);});}document[_0x25211a(0x431)](_0x314cd9['RAWwT'])[_0x25211a(0x1e8)][_0x25211a(0x3be)](_0x25211a(0x403));}function submitQuiz(){const _0x777f95=_0x5da439,_0xf04d2e={'zKvze':_0x777f95(0x1b7),'WLjOL':_0x777f95(0x283),'AKucG':function(_0x4faf3a,_0x36d09f){return _0x4faf3a!==_0x36d09f;},'yUIZs':function(_0x27c82c,_0x870863){return _0x27c82c===_0x870863;},'eGcIc':function(_0x1b1b39,_0x11fa3b){return _0x1b1b39!==_0x11fa3b;},'vcftm':'iLGgw','HpRmT':'correct','TomcJ':_0x777f95(0x3f1),'soAmL':function(_0x4b0c4f,_0x307f6d){return _0x4b0c4f(_0x307f6d);},'mRpkv':_0x777f95(0x315),'YACVT':function(_0x6f6d4a,_0x12cc12){return _0x6f6d4a-_0x12cc12;},'vEjvl':'quizPerformanceData','JNQsv':function(_0x26256b,_0x205873){return _0x26256b-_0x205873;},'tUdaD':function(_0xd40fa6){return _0xd40fa6();},'OCPfk':function(_0x26f039,_0x23fec4,_0x215832,_0x3951e1,_0x574eff){return _0x26f039(_0x23fec4,_0x215832,_0x3951e1,_0x574eff);},'XfxWv':function(_0x56e829,_0x550e39){return _0x56e829-_0x550e39;},'GvlxD':function(_0x59e60f,_0x255e0f){return _0x59e60f+_0x255e0f;}};if(timer)_0xf04d2e[_0x777f95(0x3df)](clearInterval,timer);if(!confirm(_0xf04d2e[_0x777f95(0x443)]))return;isQuizCompleted=!![];let _0x251a81=0x0,_0x494b6a=0x0;const _0x37da17=_0xf04d2e[_0x777f95(0x44a)](Date['now'](),quizStartTime);questionsData[_0x777f95(0x24e)]((_0x5503dc,_0x48b5a8)=>{const _0x3585ea=_0x777f95,_0x3cd43f={'oCHIe':_0xf04d2e['zKvze'],'hjKDI':_0xf04d2e[_0x3585ea(0x230)]},_0x1758cd=questionStates[_0x48b5a8];if(_0xf04d2e['AKucG'](_0x1758cd[_0x3585ea(0x414)],null)){if(_0xf04d2e[_0x3585ea(0x287)](_0x5503dc['choices'][_0x1758cd[_0x3585ea(0x414)]]['id'],_0x5503dc[_0x3585ea(0x450)])){if(_0xf04d2e[_0x3585ea(0x41a)](_0xf04d2e['vcftm'],_0x3585ea(0x3e8)))_0x251a81++,_0x1758cd[_0x3585ea(0x425)]=_0xf04d2e[_0x3585ea(0x456)];else{const _0xd5cf9d=_0xfe7612[_0x3585ea(0x3fe)](_0x564829[_0x3585ea(0x280)](_0x3cd43f[_0x3585ea(0x3af)]))||{},_0x37f91b=_0xd5cf9d[_0x465357];if(_0x37f91b)return _0x27ecd6=_0x37f91b['questionStates'],_0x269ea9=_0x37f91b[_0x3585ea(0x181)],_0x49ddec=_0x37f91b['currentQuestionIndex'],_0x8da7e6=_0x37f91b[_0x3585ea(0x3a0)],_0x1f674d['log'](_0x3cd43f['hjKDI']),!![];return![];}}else _0x494b6a++,_0x1758cd[_0x3585ea(0x425)]=_0xf04d2e['TomcJ'];}});const _0x5bfb88=JSON[_0x777f95(0x3fe)](localStorage[_0x777f95(0x280)](_0xf04d2e[_0x777f95(0x394)]))||[];_0x5bfb88[_0x777f95(0x17b)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x777f95(0x382)](),'totalTime':_0x37da17,'stats':{'correct':_0x251a81,'incorrect':_0x494b6a,'notAttempted':_0xf04d2e['JNQsv'](questionsData[_0x777f95(0x39a)],_0x251a81+_0x494b6a)}}),localStorage[_0x777f95(0x437)](_0xf04d2e[_0x777f95(0x394)],JSON[_0x777f95(0x427)](_0x5bfb88)),stats[_0x777f95(0x421)]=_0x251a81,stats['incorrectAnswers']=_0x494b6a,_0xf04d2e[_0x777f95(0x347)](markQuizAsCompleted),_0xf04d2e[_0x777f95(0x218)](showPerformanceAnalysis,_0x251a81,_0x494b6a,_0xf04d2e[_0x777f95(0x203)](questionsData[_0x777f95(0x39a)],_0xf04d2e[_0x777f95(0x3a2)](_0x251a81,_0x494b6a)),_0x37da17);}function showPerformanceAnalysis(_0x43fce8,_0xcf5664,_0x48f7d0,_0x301dd1){const _0x1a72ca=_0x5da439,_0x2a6bef={'tawDY':function(_0x464b0f,_0x1ee6c5){return _0x464b0f>_0x1ee6c5;},'bpfBf':function(_0x5b785c,_0x2468f0){return _0x5b785c+_0x2468f0;},'KCdsJ':function(_0x5a3c4e,_0x41d8ec){return _0x5a3c4e*_0x41d8ec;},'rQCyy':function(_0x560fc7,_0x5a9fb0){return _0x560fc7*_0x5a9fb0;},'ZRaKq':_0x1a72ca(0x30a),'KoVOo':function(_0x5f27f8,_0x2503e2){return _0x5f27f8-_0x2503e2;},'qJaIg':function(_0x2bfbc4,_0x19cec8){return _0x2bfbc4*_0x19cec8;},'gQfgv':function(_0xe643a,_0x49a522){return _0xe643a/_0x49a522;},'WKTvI':_0x1a72ca(0x399),'jfwZb':_0x1a72ca(0x3ae),'qKhAI':_0x1a72ca(0x362),'IJxjg':function(_0x2183a9,_0x2f3040){return _0x2183a9%_0x2f3040;},'gGIZT':'totalTimeResult','JFQCm':function(_0x143691,_0x432294){return _0x143691/_0x432294;},'tuOwN':_0x1a72ca(0x1ef),'UCTsa':_0x1a72ca(0x403)},_0x55ed72=document[_0x1a72ca(0x431)](_0x1a72ca(0x1b6)),_0xcf6019=_0x2a6bef[_0x1a72ca(0x20a)](_0x2a6bef[_0x1a72ca(0x1a8)](_0x43fce8,_0xcf5664),0x0)?Math['round'](_0x43fce8/_0x2a6bef['bpfBf'](_0x43fce8,_0xcf5664)*0x64):0x0,_0x1408d5=_0x2a6bef['KCdsJ'](_0x2a6bef[_0x1a72ca(0x37c)](0x2,Math['PI']),0x41),_0x12091e=document['getElementById'](_0x2a6bef[_0x1a72ca(0x2fa)]);_0x12091e[_0x1a72ca(0x2be)]['strokeDasharray']=_0x1408d5+'\x20'+_0x1408d5,_0x12091e['style'][_0x1a72ca(0x3d5)]=_0x2a6bef[_0x1a72ca(0x2ab)](_0x1408d5,_0x2a6bef[_0x1a72ca(0x1f5)](_0x2a6bef[_0x1a72ca(0x3ea)](_0xcf6019,0x64),_0x1408d5)),document[_0x1a72ca(0x431)](_0x2a6bef[_0x1a72ca(0x1c6)])[_0x1a72ca(0x373)]=_0xcf6019+'%',document[_0x1a72ca(0x431)](_0x2a6bef['jfwZb'])['textContent']=questionsData['length'],document[_0x1a72ca(0x431)](_0x2a6bef[_0x1a72ca(0x22a)])['textContent']=_0x43fce8,document['getElementById'](_0x1a72ca(0x412))[_0x1a72ca(0x373)]=_0xcf5664,document[_0x1a72ca(0x431)](_0x1a72ca(0x2e1))['textContent']=_0x48f7d0;const _0x5d11a8=Math[_0x1a72ca(0x372)](_0x2a6bef[_0x1a72ca(0x3ea)](_0x301dd1,0xea60)),_0x285e2a=Math['floor'](_0x2a6bef[_0x1a72ca(0x3ea)](_0x2a6bef[_0x1a72ca(0x35b)](_0x301dd1,0xea60),0x3e8));document['getElementById'](_0x2a6bef['gGIZT'])[_0x1a72ca(0x373)]=_0x5d11a8+':'+_0x285e2a[_0x1a72ca(0x3f0)]()['padStart'](0x2,'0');const _0x476b52=_0x2a6bef[_0x1a72ca(0x1a2)](_0x301dd1,questionsData[_0x1a72ca(0x39a)]),_0x290d3d=Math[_0x1a72ca(0x372)](_0x476b52/0xea60),_0x53204d=Math[_0x1a72ca(0x372)](_0x2a6bef[_0x1a72ca(0x3ea)](_0x476b52%0xea60,0x3e8));document[_0x1a72ca(0x431)](_0x2a6bef['tuOwN'])[_0x1a72ca(0x373)]=_0x290d3d+':'+_0x53204d[_0x1a72ca(0x3f0)]()[_0x1a72ca(0x3b4)](0x2,'0'),_0x55ed72[_0x1a72ca(0x1e8)][_0x1a72ca(0x3be)](_0x2a6bef[_0x1a72ca(0x36d)]);}function closePerformanceModal(){const _0xa19ed7=_0x5da439,_0x15871b={'UhAnn':_0xa19ed7(0x1b6),'ukLty':_0xa19ed7(0x403)};document[_0xa19ed7(0x431)](_0x15871b[_0xa19ed7(0x272)])['classList'][_0xa19ed7(0x172)](_0x15871b['ukLty']);}function reviewQuestions(){const _0x40f226=_0x5da439,_0x550dd2={'VhtSk':_0x40f226(0x1b7),'SimcY':function(_0x1f5fb1,_0x386f82){return _0x1f5fb1===_0x386f82;},'IkTnK':_0x40f226(0x1de),'pRluQ':'border-red-500','saMuC':function(_0x4be826,_0x10b614){return _0x4be826+_0x10b614;},'LBBId':_0x40f226(0x1be),'QnWwQ':_0x40f226(0x34c),'nnNzm':function(_0x7dc952,_0x1937fc){return _0x7dc952===_0x1937fc;},'mxmMB':'OenaI','BHEPD':_0x40f226(0x1b8),'vyQzY':_0x40f226(0x444),'qDFVS':_0x40f226(0x3f1),'vCGpm':_0x40f226(0x2fd),'Dyprz':_0x40f226(0x31b),'FlbNO':function(_0x2e5213,_0x17caff){return _0x2e5213+_0x17caff;},'SZWVu':function(_0x26abce,_0x3860a8){return _0x26abce===_0x3860a8;},'PSBIQ':_0x40f226(0x33a),'tWfQO':function(_0x5b969f,_0x23c94e){return _0x5b969f===_0x23c94e;},'SQrWB':_0x40f226(0x326),'XNFXb':_0x40f226(0x21a),'SkEyT':'No\x20solution\x20available.','nJpTD':_0x40f226(0x3cb)};document[_0x40f226(0x431)](_0x550dd2[_0x40f226(0x23b)])[_0x40f226(0x1e8)][_0x40f226(0x3be)](_0x40f226(0x403));const _0x2f5ab0=document[_0x40f226(0x431)](_0x40f226(0x2c4));_0x2f5ab0['innerHTML']='',questionsData[_0x40f226(0x24e)]((_0x4551f8,_0x568fb3)=>{const _0x215188=_0x40f226,_0x56abef=questionStates[_0x568fb3],_0x2e6849=_0x4551f8[_0x215188(0x450)];let _0xe63dec=_0x550dd2[_0x215188(0x243)],_0x4ba33a=_0x550dd2['QnWwQ'];if(_0x56abef[_0x215188(0x414)]!==null){const _0x33a684=_0x4551f8[_0x215188(0x37f)][_0x56abef['selectedAnswer']];if(_0x550dd2['nnNzm'](_0x33a684['id'],_0x2e6849)){if(_0x215188(0x3d4)!==_0x550dd2[_0x215188(0x250)])_0xe63dec=_0x550dd2[_0x215188(0x359)],_0x4ba33a=_0x550dd2[_0x215188(0x340)];else{if(_0x40c1f6)return;const _0x4015cd=_0x4851fa[_0x215188(0x3fe)](_0x123bab[_0x215188(0x280)](_0x215188(0x1b7)))||{};_0x4015cd[_0x4653d1]={'questionStates':_0x5a8fc8,'stats':_0x14cb7a,'currentQuestionIndex':_0x5329c8,'currentMode':_0x27142a,'status':_0x215188(0x1fb),'lastSeen':new _0x9c92d4()['toISOString']()},_0x3a2705[_0x215188(0x437)](_0x550dd2[_0x215188(0x290)],_0x43d503['stringify'](_0x4015cd));}}else _0xe63dec=_0x550dd2['qDFVS'],_0x4ba33a=_0x550dd2['vCGpm'];}const _0x262546=document[_0x215188(0x459)](_0x550dd2[_0x215188(0x2bd)]);_0x262546[_0x215188(0x2ea)]=_0x215188(0x18f)+_0xe63dec;let _0x8dd283=(_0x4551f8['choices']||[])[_0x215188(0x240)]((_0x1e7c9b,_0x56b8fa)=>{const _0x549c73=_0x215188,_0x3ac7c8=_0x56abef[_0x549c73(0x414)]===_0x56b8fa,_0x150318=_0x550dd2['SimcY'](_0x1e7c9b['id'],_0x2e6849);let _0xe6014a=_0x549c73(0x297);if(_0x150318)_0xe6014a=_0x550dd2['IkTnK'];else{if(_0x3ac7c8)_0xe6014a=_0x550dd2[_0x549c73(0x314)];}return _0x549c73(0x452)+_0xe6014a+_0x549c73(0x42f)+String[_0x549c73(0x176)](_0x550dd2[_0x549c73(0x1bb)](0x41,_0x56b8fa))+_0x549c73(0x2bb)+_0x1e7c9b[_0x549c73(0x298)]+'</span></div>';})[_0x215188(0x346)]('');const _0x18dc90=_0x4551f8[_0x215188(0x2e3)]?_0x215188(0x3ac)+_0x568fb3+_0x215188(0x1ac)+_0x4551f8[_0x215188(0x2e3)]+_0x215188(0x469):'';let _0x4febb5='';if(_0x4551f8[_0x215188(0x357)])_0x4febb5+=_0x215188(0x2a3)+_0x4551f8[_0x215188(0x357)]+_0x215188(0x1fe);if(_0x4551f8[_0x215188(0x2d5)])_0x4febb5+=_0x215188(0x17d)+_0x4551f8['explanation_audio_hin']+_0x215188(0x1fe);let _0x43fb37=(_0x4551f8['explanation_images']||[])['map'](_0x41aac0=>_0x41aac0?_0x215188(0x16b)+_0x41aac0+_0x215188(0x225):'')[_0x215188(0x346)]('');_0x262546['innerHTML']=_0x215188(0x1c0)+_0x550dd2[_0x215188(0x171)](_0x568fb3,0x1)+_0x215188(0x27f)+(_0x550dd2[_0x215188(0x235)](_0xe63dec,_0x550dd2['BHEPD'])?_0x550dd2['PSBIQ']:_0x550dd2['tWfQO'](_0xe63dec,_0x550dd2[_0x215188(0x31f)])?_0x550dd2['SQrWB']:_0x550dd2[_0x215188(0x31d)])+_0x215188(0x28f)+_0x4ba33a+'</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>'+_0x4551f8[_0x215188(0x298)]+_0x215188(0x26f)+_0x8dd283+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>'+(_0x4551f8[_0x215188(0x2d8)]||_0x550dd2[_0x215188(0x354)])+_0x215188(0x402)+_0x18dc90+_0x215188(0x19c)+_0x4febb5+_0x215188(0x19c)+_0x43fb37+_0x215188(0x32d),_0x2f5ab0[_0x215188(0x337)](_0x262546);}),initializeReviewVideos();}function initializeReviewVideos(){const _0x4d19e6=_0x5da439,_0x34cb7d={'yHMNi':_0x4d19e6(0x2d9),'OmDgb':_0x4d19e6(0x3fa),'QYQRy':_0x4d19e6(0x1a1),'HPHZj':_0x4d19e6(0x291),'nYYtd':function(_0xca02e1,_0x31069c){return _0xca02e1===_0x31069c;},'VjAZG':'SiwHe','IIHrL':function(_0x2c1816,_0x36ea57,_0x276a78){return _0x2c1816(_0x36ea57,_0x276a78);},'Ncsjr':'Cbmaq','VSApg':'video[data-src]'};document['querySelectorAll'](_0x34cb7d[_0x4d19e6(0x440)])[_0x4d19e6(0x24e)](_0xcf5f60=>{const _0x442a66=_0x4d19e6,_0x12ca24=_0xcf5f60[_0x442a66(0x338)][_0x442a66(0x1af)];if(_0x12ca24&&_0x12ca24[_0x442a66(0x41f)](_0x34cb7d[_0x442a66(0x204)])){if(_0x34cb7d[_0x442a66(0x1b3)](_0x442a66(0x183),_0x34cb7d[_0x442a66(0x294)]))return _0x259ea9[_0x442a66(0x3f0)]()[_0x442a66(0x381)](NqBrvG[_0x442a66(0x445)])[_0x442a66(0x3f0)]()['constructor'](_0x4d6c1d)[_0x442a66(0x381)](NqBrvG[_0x442a66(0x445)]);else _0x34cb7d[_0x442a66(0x3b8)](setupVideo,_0xcf5f60,_0x12ca24);}else _0x12ca24&&(_0x34cb7d[_0x442a66(0x3b3)]===_0x34cb7d[_0x442a66(0x3b3)]?_0xcf5f60[_0x442a66(0x1af)]=_0x12ca24:(_0xa3a5f8(),_0x47f107[_0x442a66(0x431)](_0x34cb7d['OmDgb'])['style'][_0x442a66(0x38f)]=_0x34cb7d['QYQRy']));});}function retakeQuiz(){const _0x531a88=_0x5da439,_0x55a5e4={'qXXDZ':function(_0x1410e7,_0x253771){return _0x1410e7(_0x253771);},'uRVBT':'Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','lICQZ':function(_0x40fe71,_0x5593dd){return _0x40fe71===_0x5593dd;},'goqto':_0x531a88(0x27d),'cvsWG':_0x531a88(0x1f8),'pOrhk':function(_0x5056c0){return _0x5056c0();}};_0x55a5e4[_0x531a88(0x2c8)](confirm,_0x55a5e4[_0x531a88(0x27c)])&&(_0x55a5e4[_0x531a88(0x1a6)](_0x55a5e4[_0x531a88(0x392)],_0x531a88(0x27d))?(window[_0x531a88(0x3c9)][_0x531a88(0x260)]['endsWith'](_0x55a5e4[_0x531a88(0x321)])&&localStorage[_0x531a88(0x2aa)](_0x531a88(0x38d)),_0x55a5e4[_0x531a88(0x239)](clearProgress),location[_0x531a88(0x3fd)]()):_0x350617[_0x531a88(0x1a3)](_0x531a88(0x1ff))['forEach'](_0x6e372b=>{const _0x549f70=_0x531a88,_0x25332c=_0x6e372b['dataset'][_0x549f70(0x1af)];if(_0x25332c&&_0x25332c[_0x549f70(0x41f)](_0x549f70(0x291)))_0x2a02d8(_0x6e372b,_0x25332c);else _0x25332c&&(_0x6e372b[_0x549f70(0x1af)]=_0x25332c);}));}function loadBookmarkedQuestions(){const _0x25a0a4=_0x5da439,_0x21ae08={'FHOBT':function(_0x201b93,_0x1303f7){return _0x201b93<_0x1303f7;}},_0x333833=JSON[_0x25a0a4(0x3fe)](localStorage['getItem'](_0x25a0a4(0x2c6)))||[];_0x333833[_0x25a0a4(0x24e)](_0x56bbb4=>{const _0x5eda6a=_0x25a0a4;_0x56bbb4['quizFile']['includes'](quizName[_0x5eda6a(0x475)]()[_0x5eda6a(0x2e8)](/ /g,'-'))&&(_0x21ae08[_0x5eda6a(0x1eb)](_0x56bbb4['questionIndex'],questionsData[_0x5eda6a(0x39a)])&&(questionStates[_0x56bbb4[_0x5eda6a(0x1b1)]][_0x5eda6a(0x211)]=!![]));});}function toggleBookmark(){const _0x1dd876=_0x5da439,_0xc501bb={'KlMEP':_0x1dd876(0x307),'RgxCT':_0x1dd876(0x3eb),'nHxDT':function(_0x5eac69,_0x3f8956){return _0x5eac69===_0x3f8956;},'Dpwho':function(_0x5aaacd){return _0x5aaacd();}},_0x590522=!questionStates[currentQuestionIndex][_0x1dd876(0x211)];questionStates[currentQuestionIndex][_0x1dd876(0x211)]=_0x590522;let _0x23fd78=JSON['parse'](localStorage['getItem']('bookmarkedQuestions'))||[];if(_0x590522){const _0x6a2baa={'quizName':quizName,'quizFile':window['location'][_0x1dd876(0x260)][_0x1dd876(0x1c5)]('/')['pop'](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x1dd876(0x382)]()};_0x23fd78[_0x1dd876(0x17b)](_0x6a2baa);}else _0xc501bb[_0x1dd876(0x231)]('eDGgA',_0x1dd876(0x19b))?_0x23fd78=_0x23fd78[_0x1dd876(0x34d)](_0x356427=>!(_0x356427['quizFile'][_0x1dd876(0x41f)](quizName[_0x1dd876(0x475)]()[_0x1dd876(0x2e8)](/ /g,'-'))&&_0x356427[_0x1dd876(0x1b1)]===currentQuestionIndex)):_0x51d7d9['getElementById'](_0xc501bb[_0x1dd876(0x383)])[_0x1dd876(0x1e8)][_0x1dd876(0x175)](_0xc501bb[_0x1dd876(0x24c)]);localStorage[_0x1dd876(0x437)](_0x1dd876(0x2c6),JSON[_0x1dd876(0x427)](_0x23fd78)),updateBookmarkButton(),_0xc501bb[_0x1dd876(0x318)](updateQuestionNav);}function updateBookmarkButton(){const _0x439e20=_0x5da439,_0x36f97b={'CmeeT':'bookmarkText','DozGG':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','fdSEN':'Bookmark'},_0x372c95=document['getElementById']('bookmarkBtn'),_0x587b25=document[_0x439e20(0x431)](_0x36f97b['CmeeT']),_0x3a9a15=questionStates[currentQuestionIndex]['bookmarked'];_0x372c95[_0x439e20(0x2ea)]=_0x3a9a15?_0x439e20(0x3ec):_0x36f97b[_0x439e20(0x2b6)],_0x587b25[_0x439e20(0x373)]=_0x3a9a15?_0x439e20(0x33e):_0x36f97b[_0x439e20(0x200)];}function toggleMarkForReview(){questionStates[currentQuestionIndex]['markedForReview']=!questionStates[currentQuestionIndex]['markedForReview'],updateMarkReviewButton(),updateQuestionNav();}function updateMarkReviewButton(){const _0x25ace0=_0x5da439,_0x47409f={'ZCkgp':'markReviewBtn','BbXEG':_0x25ace0(0x3ed),'rQKYX':_0x25ace0(0x21b),'nAzHN':_0x25ace0(0x3b1),'YZPqB':_0x25ace0(0x245),'RRWCt':_0x25ace0(0x38a)},_0x3f1753=document[_0x25ace0(0x431)](_0x47409f[_0x25ace0(0x448)]),_0x7fdee2=document[_0x25ace0(0x431)](_0x47409f['BbXEG']),_0x486ba0=questionStates[currentQuestionIndex][_0x25ace0(0x423)];_0x3f1753[_0x25ace0(0x2ea)]=_0x486ba0?_0x47409f[_0x25ace0(0x219)]:_0x47409f[_0x25ace0(0x1b2)],_0x7fdee2[_0x25ace0(0x373)]=_0x486ba0?_0x47409f['YZPqB']:_0x47409f['RRWCt'];}function previousQuestion(){const _0x3c6404=_0x5da439,_0x226693={'bylhr':function(_0x51a0f6,_0x2483bf){return _0x51a0f6-_0x2483bf;},'CNKft':function(_0x4e43ec){return _0x4e43ec();}};currentQuestionIndex>0x0&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x3c6404(0x281)]+=_0x226693[_0x3c6404(0x30e)](Date[_0x3c6404(0x382)](),questionStartTime)),currentQuestionIndex--,_0x226693['CNKft'](displayQuestion),_0x226693[_0x3c6404(0x2eb)](saveProgress));}function nextQuestion(){const _0x4c3678=_0x5da439,_0x77ceb5={'acvKQ':function(_0x21f6b5){return _0x21f6b5();},'hEkYG':_0x4c3678(0x330),'NaxbB':'testModeReviewLegend','LamxW':_0x4c3678(0x3d0),'WBrhf':function(_0x18c2d0,_0xa0dd10){return _0x18c2d0===_0xa0dd10;},'lPZUc':_0x4c3678(0x27b),'qLeuY':'block','RBwch':_0x4c3678(0x303),'eOYkH':_0x4c3678(0x361),'OlEXQ':_0x4c3678(0x1a1),'pVDMx':function(_0x2a86b6,_0x91ec6a){return _0x2a86b6(_0x91ec6a);},'WMFlg':function(_0x53dbd4,_0x449461){return _0x53dbd4>=_0x449461;},'KjeQE':function(_0x2962ed,_0x3be5eb){return _0x2962ed<_0x3be5eb;},'XjXYM':function(_0x47a592,_0x5a542e){return _0x47a592-_0x5a542e;},'zjyEn':function(_0x1ca442){return _0x1ca442();},'PWddw':function(_0x3cba26,_0x1fc747){return _0x3cba26===_0x1fc747;},'Ziwsb':_0x4c3678(0x436),'vTXLk':'KJsbV','LWgUA':_0x4c3678(0x2da),'fJIxK':_0x4c3678(0x3f8),'fCMUN':_0x4c3678(0x3c3),'ztnwZ':function(_0x52931a){return _0x52931a();},'srVxx':function(_0x89a882,_0x2603ba){return _0x89a882(_0x2603ba);},'AIJSZ':'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','KkSiX':function(_0x45739c){return _0x45739c();}};questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x77ceb5[_0x4c3678(0x275)](Date[_0x4c3678(0x382)](),questionStartTime));if(_0x77ceb5['KjeQE'](currentQuestionIndex,_0x77ceb5[_0x4c3678(0x275)](questionsData[_0x4c3678(0x39a)],0x1)))currentQuestionIndex++,_0x77ceb5[_0x4c3678(0x238)](displayQuestion),_0x77ceb5[_0x4c3678(0x1bc)](saveProgress);else{if(_0x77ceb5[_0x4c3678(0x207)](_0x77ceb5[_0x4c3678(0x328)],_0x77ceb5['vTXLk']))_0x46ffd4[_0x4c3678(0x316)](),_0x77ceb5[_0x4c3678(0x1bc)](_0x322ccd);else{if(_0x77ceb5['WBrhf'](currentMode,'test')||currentMode==='timed_exam'){if(_0x77ceb5['LWgUA']!==_0x77ceb5[_0x4c3678(0x309)])confirm(_0x77ceb5[_0x4c3678(0x35e)])&&_0x77ceb5['ztnwZ'](submitQuiz);else{_0xe69c10=_0x421118[_0x4c3678(0x382)]();const _0x2cf246=_0xc177ee[_0x4c3678(0x431)](_0x77ceb5['hEkYG']),_0x28bc31=_0x53a0f9[_0x4c3678(0x431)](_0x4c3678(0x2f8)),_0x31cc82=_0x1a084b[_0x4c3678(0x431)](_0x77ceb5['NaxbB']),_0x4bdc96=_0x1f7870===_0x77ceb5[_0x4c3678(0x33f)]||_0x77ceb5[_0x4c3678(0x324)](_0x2be801,_0x4c3678(0x306));_0x57c777[_0x4c3678(0x431)](_0x4c3678(0x2b3))[_0x4c3678(0x2be)][_0x4c3678(0x38f)]=_0x4bdc96?_0x77ceb5[_0x4c3678(0x398)]:_0x77ceb5['qLeuY'],_0x3b81e5[_0x4c3678(0x431)](_0x77ceb5[_0x4c3678(0x252)])[_0x4c3678(0x2be)][_0x4c3678(0x38f)]=_0x4bdc96?_0x77ceb5[_0x4c3678(0x398)]:_0x77ceb5[_0x4c3678(0x477)],_0x562279[_0x4c3678(0x431)](_0x4c3678(0x395))[_0x4c3678(0x2be)][_0x4c3678(0x38f)]=_0x4bdc96?_0x77ceb5[_0x4c3678(0x477)]:'none',_0x468412[_0x4c3678(0x431)](_0x77ceb5[_0x4c3678(0x3d6)])[_0x4c3678(0x2be)]['display']=_0x4bdc96?_0x77ceb5[_0x4c3678(0x477)]:_0x77ceb5[_0x4c3678(0x398)],_0x2cf246[_0x4c3678(0x2be)][_0x4c3678(0x38f)]=_0x4bdc96?_0x4c3678(0x27b):_0x77ceb5[_0x4c3678(0x374)],_0x28bc31['style'][_0x4c3678(0x38f)]=_0x4bdc96?_0x77ceb5['OlEXQ']:_0x77ceb5[_0x4c3678(0x398)],_0x31cc82[_0x4c3678(0x2be)][_0x4c3678(0x38f)]=_0x4bdc96?_0x77ceb5['OlEXQ']:_0x77ceb5[_0x4c3678(0x398)],(_0x2ba941==='timed_study'||_0x77ceb5[_0x4c3678(0x324)](_0x44a7d6,_0x4c3678(0x306)))&&_0x23662f['getElementById']('timerContainer')[_0x4c3678(0x1e8)][_0x4c3678(0x3be)](_0x4c3678(0x403)),!_0x77ceb5[_0x4c3678(0x3bf)](_0x4d414c,_0x938db8)&&_0x77ceb5[_0x4c3678(0x3a3)](_0x5ccbd9,0x0)&&_0x77ceb5[_0x4c3678(0x302)](_0x5ab446,_0x1c9d0d[_0x4c3678(0x39a)])&&(_0x51a589=_0x4ad3bc),_0x77ceb5[_0x4c3678(0x1bc)](_0x4a01ca),_0x77ceb5['acvKQ'](_0x57d149),_0x77ceb5[_0x4c3678(0x1bc)](_0x2616a7),_0x77ceb5[_0x4c3678(0x1bc)](_0x518929);}}else _0x77ceb5[_0x4c3678(0x28d)](confirm,_0x77ceb5[_0x4c3678(0x278)])&&(currentQuestionIndex=0x0,_0x77ceb5[_0x4c3678(0x3d1)](displayQuestion),_0x77ceb5[_0x4c3678(0x238)](saveProgress));}}}function startTimer(){const _0x132771=_0x5da439,_0x44d4df={'nBDlC':function(_0x263d2c){return _0x263d2c();},'gXNuu':function(_0x7f34a9,_0x525d63){return _0x7f34a9(_0x525d63);},'IFiOB':function(_0x5229f4,_0x5388c0){return _0x5229f4===_0x5388c0;},'hwaIp':function(_0x1e2949){return _0x1e2949();},'matge':function(_0x3b6449,_0x82c835,_0x89d5aa){return _0x3b6449(_0x82c835,_0x89d5aa);}};if(timer)_0x44d4df[_0x132771(0x193)](clearInterval,timer);timeRemaining=0x78,_0x44d4df[_0x132771(0x2e7)](updateTimerDisplay),timer=_0x44d4df[_0x132771(0x43d)](setInterval,()=>{const _0x426ba7=_0x132771;timeRemaining--,_0x44d4df['nBDlC'](updateTimerDisplay),timeRemaining<=0x0&&(_0x44d4df[_0x426ba7(0x193)](clearInterval,timer),_0x44d4df[_0x426ba7(0x2c5)](currentMode,_0x426ba7(0x306))?_0x44d4df[_0x426ba7(0x3f7)](submitQuiz):nextQuestion());},0x3e8);}function updateTimerDisplay(){const _0x2bf23f=_0x5da439,_0x355b57={'BlXhO':function(_0x49b5bf,_0x42c9de){return _0x49b5bf/_0x42c9de;},'huCnq':_0x2bf23f(0x24d),'NbGiD':function(_0x55c80c,_0x5b86c7){return _0x55c80c+_0x5b86c7;}},_0x500ffe=Math[_0x2bf23f(0x372)](_0x355b57[_0x2bf23f(0x376)](timeRemaining,0x3c)),_0x48288b=timeRemaining%0x3c;document[_0x2bf23f(0x431)](_0x355b57['huCnq'])[_0x2bf23f(0x373)]=_0x355b57[_0x2bf23f(0x3bc)](_0x500ffe+':',_0x48288b[_0x2bf23f(0x3f0)]()[_0x2bf23f(0x3b4)](0x2,'0'));}function toggleSidebar(){const _0x22fc42=_0x5da439,_0x11908b={'Thfnc':'open'};document[_0x22fc42(0x431)](_0x22fc42(0x307))[_0x22fc42(0x1e8)][_0x22fc42(0x175)](_0x11908b[_0x22fc42(0x404)]);}document['addEventListener'](_0x5da439(0x3f6),()=>{const _0x5c61d5=_0x5da439,_0x1d9246={'rIXaY':_0x5c61d5(0x41c),'lOQPc':_0x5c61d5(0x31a),'hdkVI':'totalQuestions','zBewC':_0x5c61d5(0x28c),'UuQhn':function(_0x113511){return _0x113511();},'vahPT':_0x5c61d5(0x27b),'QcdYf':function(_0x29d306){return _0x29d306();},'TIAkF':function(_0x275a43,_0x230f0c){return _0x275a43!==_0x230f0c;},'pDkew':function(_0x5d40f4){return _0x5d40f4();},'EqJkD':_0x5c61d5(0x1a1),'bZmpW':_0x5c61d5(0x1f8),'QWnsB':function(_0x31503c){return _0x31503c();},'AEfvE':function(_0x4b5af3){return _0x4b5af3();}};if(resume){if(_0x1d9246[_0x5c61d5(0x2ad)](loadProgress))document[_0x5c61d5(0x431)](_0x5c61d5(0x3fa))[_0x5c61d5(0x2be)][_0x5c61d5(0x38f)]=_0x1d9246[_0x5c61d5(0x1d7)],_0x1d9246[_0x5c61d5(0x3fc)](initializeQuiz);else{if(_0x1d9246[_0x5c61d5(0x186)](_0x5c61d5(0x45d),_0x5c61d5(0x45d))){const _0x2dccb1=_0x2fd38b[_0x5c61d5(0x3fe)](_0x1c96ac[_0x5c61d5(0x280)](_0x5c61d5(0x38d)));if(_0x2dccb1){const _0x531422=_0x5c61d5(0x38e)[_0x5c61d5(0x1c5)]('|');let _0x3fcf5a=0x0;while(!![]){switch(_0x531422[_0x3fcf5a++]){case'0':_0x1f7f4a[_0x5c61d5(0x431)](_0x1d9246[_0x5c61d5(0x417)])['textContent']=_0x4827e1[_0x5c61d5(0x346)](_0x1d9246['lOQPc']);continue;case'1':_0xfc17c0=_0x2dccb1['name'];continue;case'2':_0x2d60d3[_0x5c61d5(0x431)](_0x1d9246['hdkVI'])[_0x5c61d5(0x373)]=_0x4fb382[_0x5c61d5(0x39a)];continue;case'3':_0x3d9e59=_0x2dccb1[_0x5c61d5(0x40f)];continue;case'4':_0x338eeb['title']=_0x320728+_0x1d9246['zBewC'];continue;case'5':_0x5a5af2=_0x2dccb1[_0x5c61d5(0x19d)];continue;}break;}}}else _0x1d9246[_0x5c61d5(0x23f)](clearProgress),document[_0x5c61d5(0x431)]('modeModal')[_0x5c61d5(0x2be)][_0x5c61d5(0x38f)]=_0x1d9246['EqJkD'];}}else!window[_0x5c61d5(0x3c9)]['pathname'][_0x5c61d5(0x198)](_0x1d9246[_0x5c61d5(0x18e)])?(_0x1d9246[_0x5c61d5(0x42a)](clearProgress),document['getElementById']('modeModal')[_0x5c61d5(0x2be)][_0x5c61d5(0x38f)]=_0x1d9246[_0x5c61d5(0x377)]):_0x1d9246[_0x5c61d5(0x356)](initializeQuiz);}),document[_0x5da439(0x323)]('keydown',function(_0x4538c3){const _0x477540=_0x5da439,_0x5d4cfc={'KxVfk':function(_0xf9487b,_0x434adf){return _0xf9487b-_0x434adf;},'TILMQ':'.option-button','rQiNK':function(_0x394c99,_0x42a62c){return _0x394c99<_0x42a62c;},'VyWoT':function(_0x4cef47,_0x243d13){return _0x4cef47(_0x243d13);},'yhHZK':function(_0x1dc44a,_0x2fdbf6){return _0x1dc44a===_0x2fdbf6;},'HOcLr':_0x477540(0x1b8),'PIymu':_0x477540(0x3f1),'YHSlQ':_0x477540(0x3fa),'jKGgu':'none','BIfJA':function(_0x528f8d,_0xb7255f){return _0x528f8d===_0xb7255f;},'pwmdh':_0x477540(0x1b6),'rLIrD':_0x477540(0x403),'HXoNv':function(_0xa377b2,_0x2a104a){return _0xa377b2===_0x2a104a;},'JiJtS':_0x477540(0x426),'VLxJn':function(_0x420929,_0x31dbac){return _0x420929===_0x31dbac;},'iaMEM':_0x477540(0x192),'qYCri':'LIkCh','ROUNR':function(_0x18cc80,_0x40f315){return _0x18cc80===_0x40f315;},'bIACp':'YyJvK','NlNSa':function(_0x437d1a){return _0x437d1a();},'UNlYK':function(_0x229bd8,_0x535f0d){return _0x229bd8===_0x535f0d;},'RTgxM':function(_0x1718e4,_0x5af42b){return _0x1718e4===_0x5af42b;},'WaUDM':'KWcYp','zusrG':function(_0xffb005,_0x411a1e){return _0xffb005===_0x411a1e;},'shPSf':function(_0x76ffe,_0x59531d){return _0x76ffe===_0x59531d;},'pWZaG':_0x477540(0x306),'emvrZ':function(_0x3573b1){return _0x3573b1();},'ZIKhl':function(_0x5f4e69,_0x1cdce7){return _0x5f4e69===_0x1cdce7;},'TYtwi':function(_0x4d0ff2,_0x10f0a3){return _0x4d0ff2===_0x10f0a3;},'EjErU':_0x477540(0x3d0),'oBNqV':function(_0x238518){return _0x238518();}};if(document[_0x477540(0x431)](_0x5d4cfc['YHSlQ'])[_0x477540(0x2be)][_0x477540(0x38f)]!==_0x5d4cfc[_0x477540(0x2f3)])return;if(_0x5d4cfc[_0x477540(0x1cd)](document[_0x477540(0x431)](_0x5d4cfc[_0x477540(0x3a6)])[_0x477540(0x1e8)][_0x477540(0x2b7)](_0x5d4cfc[_0x477540(0x2a4)]),![]))return;if(_0x4538c3[_0x477540(0x408)]>='1'&&_0x4538c3[_0x477540(0x408)]<='4'){const _0xa5f6c1=_0x5d4cfc[_0x477540(0x2a1)](_0x5d4cfc[_0x477540(0x2c1)](parseInt,_0x4538c3[_0x477540(0x408)]),0x1),_0x5f0633=document[_0x477540(0x1a3)](_0x477540(0x180));if(_0x5d4cfc[_0x477540(0x336)](_0xa5f6c1,_0x5f0633[_0x477540(0x39a)]))_0x5d4cfc[_0x477540(0x2c1)](selectOption,_0xa5f6c1);}else{if(_0x5d4cfc['HXoNv'](_0x4538c3['key'],_0x5d4cfc[_0x477540(0x184)])){if(_0x5d4cfc[_0x477540(0x174)](_0x5d4cfc['iaMEM'],_0x5d4cfc['qYCri'])){const _0x4083a5=_0x5d4cfc[_0x477540(0x2a1)](_0x432f27(_0x33c356['key']),0x1),_0x399d9b=_0x3d09c2['querySelectorAll'](_0x5d4cfc[_0x477540(0x270)]);if(_0x5d4cfc[_0x477540(0x336)](_0x4083a5,_0x399d9b[_0x477540(0x39a)]))_0x5d4cfc[_0x477540(0x2c1)](_0x2e1590,_0x4083a5);}else previousQuestion();}else{if(_0x5d4cfc[_0x477540(0x1cd)](_0x4538c3[_0x477540(0x408)],_0x477540(0x34b))||_0x5d4cfc[_0x477540(0x3c0)](_0x4538c3['key'],'\x20')){if(_0x5d4cfc['ROUNR'](_0x5d4cfc[_0x477540(0x21c)],_0x5d4cfc['bIACp']))_0x4538c3[_0x477540(0x316)](),_0x5d4cfc[_0x477540(0x209)](nextQuestion);else{const _0x41c0f9=_0x201fcf[_0x477540(0x16e)](_0x473dc5,arguments);return _0x465de1=null,_0x41c0f9;}}else{if(_0x4538c3[_0x477540(0x408)][_0x477540(0x475)]()==='b'&&(_0x5d4cfc[_0x477540(0x1cd)](currentMode,_0x477540(0x25c))||_0x5d4cfc['UNlYK'](currentMode,'timed_study'))){if(_0x5d4cfc[_0x477540(0x1a4)](_0x477540(0x29d),_0x5d4cfc[_0x477540(0x185)]))_0x5d4cfc[_0x477540(0x209)](toggleBookmark);else{_0x29768a['classList'][_0x477540(0x3be)](_0x477540(0x29c));if(_0x5d4cfc['yhHZK'](_0x14042e,_0x227c09))_0x1c1dfe[_0x477540(0x1e8)]['add'](_0x5d4cfc[_0x477540(0x17c)]);else{if(_0x5d4cfc[_0x477540(0x256)](_0x375aa6,_0x455aee)&&!_0x2f9871)_0x1b0628[_0x477540(0x1e8)]['add'](_0x5d4cfc[_0x477540(0x21f)]);}}}else{if(_0x5d4cfc[_0x477540(0x17f)](_0x4538c3[_0x477540(0x408)][_0x477540(0x475)](),'m')&&(_0x5d4cfc[_0x477540(0x16f)](currentMode,_0x477540(0x3d0))||currentMode===_0x5d4cfc[_0x477540(0x378)]))_0x5d4cfc[_0x477540(0x1da)](toggleMarkForReview);else _0x5d4cfc[_0x477540(0x44c)](_0x4538c3[_0x477540(0x408)][_0x477540(0x475)](),'s')&&(_0x5d4cfc[_0x477540(0x2f5)](currentMode,_0x5d4cfc[_0x477540(0x418)])||_0x5d4cfc[_0x477540(0x3c0)](currentMode,_0x5d4cfc[_0x477540(0x378)]))&&_0x5d4cfc['oBNqV'](submitQuiz);}}}}});</script>

</body></html>